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Abstract 
 
 
THE EFFECTS OF FAMILY FUNCTIONING AND TANGIBLE SUPPORT ON 
TREATMENT OUTCOMES IN AN OPIOID ADDICTED POPULATION 
 
By Nathasha C. Hahn, M.S. 
 
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctorate of 
Philosophy at Virginia Commonwealth University 
 
Virginia Commonwealth University, 2015. 
 
Director: Shawn Utsey, Ph.D. 
Title: Professor 
Department of Psychology 
Former Chair, Department of African American Studies 
 
The effects of family functioning and tangible support from family members are examined 
in an opiate addicted population. The study specifically assessed drug use, self-efficacy, and 
quality of life as treatment outcomes of interest. There have been mixed findings in the literature 
in regards to how families influence rehabilitation from substance use. Specially, previous research 
has shown that families can further patients’ recovery, while other findings have shown that 
families can impede patients’ recovery from substance use. The aim of this study was to analyze 
potentially contributing factors related to the family system, to gain a stronger understanding of 
how families influence recovery for patients receiving treatment for their opiate addiction. The 
study included 110 participants who were patients from a medically assisted recovery facility. The 
participants took survey measures regarding beliefs about their self-efficacy, quality of life, family 
functioning, and tangible support received from family members. The participant’s drug use 
information was verified through facility databases of current urine screens and prescription use. 
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Survey results did not substantiate the hypotheses that tangible support influences treatment 
outcomes. However, hypotheses that family functioning would positively influence self-efficacy 
and quality of life were supported. The belief that family functioning would have a negative 
relationship with the participant’s drug usage was not corroborated by the data, as there was no 
relationship found between these variables. Finally, there was no moderating relationship observed 
between family functioning, tangible support, and treatment outcomes. This was contrary to 
expectations that a moderating relationship would be present. Implications of how the study’s 
findings can inform research and clinical interventions in an opiate addicted population are 
discussed.
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Statement of the Problem 
 
The United Nations World Drug Report of 2012 revealed that over 230 million people 
worldwide use illegal drugs at least once a year. Of these, 27 million are addicted to unlawful 
substances. The report showed that approximately 11.8 million people experienced a disability 
attributable to illegal drug use in the year prior, and around 200,000 people die annually from drug 
use. In the United States, about 22 million people will be suffering from substance abuse at a given 
time (U.S.D.H.H.S., 2003). In 2003, it was revealed that around 94% of substance abusers were 
not in treatment (U.S.D.H.H.S., 2003). More recent reports showed that no more than one-third of 
substance abusers are receiving treatment (Compton, Thomas, Stinson, & Grant, 2007). The drop-
out rate is between 21 to 50% for those who do engage in detoxification treatment and outpatient 
programs (Gilchrist, Langohr, Fonseca, Muga, & Torrens, 2012; McHugh, Murray, Hearon, Pratt, 
Pollack, Safren, 2013; Santonja-Gómez, Sánchez-Hervás, Secades-Villa, Zacarés-Romaguera, 
García-Rodríguez, & García-Fernández, 2010; Specka, Buchholz, Kuhlmann, Rist, & Scherbaum, 
2011). 
There are macro and micro level benefits when addicts engage in and complete substance 
abuse treatment. On a societal level, those who remain in treatment programs longer report less 
indiscriminant sexual and injecting behaviors, as well as lower seroconversion infection rates. HIV 
infection and hepatitis risk reduction are also associated with completed treatment and lengthier 
stays in treatment (Bertschy, 1995; Caddow, 1974; Langendam, van Brussel, Coutinho, & van 
Ameijden, 2000; Metzger, Navaline, & Woody, 1998; Ponizovsky & Grinshpoon, 2007).  
Involvement in the work force, engaging in abstinence, and lower crime rate are also societal 
benefits for individuals recovering from addiction as they participate in and complete therapy 
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(APA, 2007; He, Wang, Xia, Mandel, Chen, Zhao, Han, & Ling, 2011; Stark, 1992). Individual 
level benefits include improved relationships with family members, increased personal income, 
overall improved quality of life, and fewer relapses (He, Wang, Xia, Mandel, Chen, Zhao, Han, & 
Ling, 2011; Stark, 1992).  
On the contrary, when recovering addicts engage in treatment then leave prematurely there 
are consequences both for themselves and society as whole. Patients who drop out of treatment 
experience poorer health, legal and financial troubles that increase difficulty of taking care of their 
health, higher crime involvement, and increased spreading of HIV. On a micro level treatment 
drop out has shown to impair relationships with loved ones, greater risk of relapse, and higher 
association with severe levels of depression (Brewer, Catalano, Haggerty, Gainey, & Fleming, 
1998; Curran, Kirchner, Worley, Rookey, & Booth, 2002; Levin, Evans, Vosburg, Horton, Brooks, 
& Ng, 2004; Moos, Pettit, & Gruber, 1995; Stark, 1992; UNODC, 2012).  
There are a variety of terms used in substance abuse and family system research that need 
to be identified and defined to have a greater understanding of the literature. Portions of the paper 
will discuss an identified patient. This term is in reference to the individual whose problems are 
causing distress in their family system (Day, 2008). Despite this distress, many families are 
accustomed to the identifying patient producing discord in the family as this maintains their 
familial homeostasis. Homeostasis is the self-regulation of the family system that includes norms 
and expectations to which the family has been conditioned to adapt to. Families are usually 
resistant to anything that could change their homeostasis, as it would interfere with their normative 
family operations, and their individual roles and expectations (Day, 2008; Jackson & Weakland, 
1961; Nichols & Schwartz, 2004). There are several drugs that are used to provide medical 
assistance with opioid use reduction. These include medications such as methadone, 
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buprenorphine (which includes Suboxone), Naltrexone, and Naloxone (Buprenorphine, 2014). 
Methadone is the most widely used opioid medical treatment. Thus for the purposes of maintaining  
authors’ terms from cited research, populations and facilities will often be referred to as 
“methadone facility” or “methadone population,” which is used to reference the full class of 
substances designed to treat opioid addiction.  When receiving treatment for substance abuse, it is 
not uncommon for identified patients to experience a relapse. A relapse is specifically defined as 
“any use of alcohol or drugs other than nicotine” (Ellis, Bernichon, Yu, Roberts, Herrell, 2004, pg. 
213). Continued use of the problem substance after relapse can lead to dropping out of treatment, 
which would be considered failure to compete treatment (Brorson, Arnevik, Rand-Hendriksen, 
Duckert, 2013). 
Chronic Opioid Use 
Opium comes from a poppy plant and is a chemical that can reduce pain symptoms. Opiates 
are the class of drugs used for pain treatment (Melemis, 2014). Prescription opiates include 
Oxycontin (oxycodone), Vicodin (hydrocodone and acetaminophen), Dilaudid (hydromorphone), 
and morphine. Heroin is an illegal drug that also falls under the opiate classification (Case-Lo, 
2012). Opioid is the formal term for synthetic opiate drugs, but is now officially used to refer to 
all forms of opium-based substances which included any natural, synthetic, and semi- synthetic 
forms. (Opiates/Opioids, 2014). 
Individuals use opioids to manage their pain symptoms, however, there are a variety of 
consequences that are produced from long term opioid use. Side effects of long term opioid use 
include hypersensitivity to certain pain in the body. Disordered breathing patterns can develop in 
the opioid user during periods of slumber or alertness (Walker, Farney, Rhondeau, Boyle, 
  
 
4 
 
Valentine, Cloward. & Shilling, 2007). Opioid users who are older in age may experience excess 
dizziness and sedation, which is associated with a greater possibility of bone fractures from falling 
(Saunders, Dunn, Merrill, Sullivan, Weisner, Braden, Brennan, Psaty, & Von Korff, 2010). 
Consequences of opioid use include loss of libido, infertility, fatigue, depression, anxiety, loss of 
muscle strength and mass, osteoporosis, and compression fractures (Katz & Mazer, 2009). 
Neuropsychological consequences such as attention deficits, concentration difficulty, recall 
challenges, and decreased visuospatial skills and psychomotor speed are side effects that have been 
found in both short term and long term opioid using populations (Gruber, Silveri, & Yurgelun-
Todd, 2007). Irregular and decreased hormone levels are endocrine consequences of chronic 
opioid use. Female opioid users have lower progesterone levels and men have lower testosterone 
levels. Both men and women are susceptible to developing hypogonadotropic hypogonadism, 
which is when the body is under producing the appropriate sex hormone. Women can also develop 
amenorrhea, which is an irregular menstrual cycle. Both sexes can experience a decrease in cortisol 
levels (Abs, Verhelst, Maeyaert, Van Buyten, Opsomer, Adriaensen, Verlooy, Van Havenbergh, 
Smet, & Van Acker, 2000). 
A major consequence of chronic use of opioid drugs is that this usage can lead to chemical 
dependence. Thus attempts to discontinue use of the opium based substances brings about severe 
withdrawals symptoms including low energy, irritability, anxiety, agitation, insomnia, runny nose, 
lacrimation, hot and cold sweats, goose bumps, yawning, muscle twitching and aches and pains, 
abdominal cramping, nausea, vomiting, diarrhea, strong opioid cravings, drug-seeking behavior, 
anorexia, or increased respiratory rate or blood pressure (Gruber et al., 2007; White, 2004; 
Melemis, 2014).  
  
 
5 
 
Methadone Treatment 
For individuals who desire to end their opioid dependence but do not want to endure 
withdrawal symptoms, they may choose to receive medically assisted treatment from facilities 
such as a methadone clinic. Methadone is a synthetic long lasting opioid that is used to treat 
withdrawal symptoms in opioid addicts (Broekhuysen, 2000; Case-Lo, 2012; Ramer, Zaslove, 
Langan, 1971). Methadone works as an opioid receptor agonist as a part of the long term 
detoxification process (Prus, 2013). They bind to the opioid receptors and send signals to the brain 
that mirror the effects of the drug such as improved mood and emotions, slowed breathing, and 
decreased pain symptoms (Case-Lo, 2012; Opioid/Opiate, 2014). 
The detoxification process is approximately 180 days of daily methadone dosage, but often 
times the process can last for a longer period if so desired by the patient or their medical treatment 
provider (Prus, 2013). Being that it is the patient’s goal to recover from opioid dependency, they 
should discontinue all use when enrolled in detoxification treatment. The methadone clinic staff 
conduct periodic drug testing to monitor the patients’ drug use, as using the methadone with 
another opioid can be fatal (Prus, 2013). Methadone clinics are regulated by the Food and Drug 
Administration (Zarkin, Dunlap, & Homsi, 2006). Treatment from these facilities are both 
federally funded and private-fee-for-service regimens (Douglas, Speckart, Booth, & Ryan, 1989). 
In addition to providing medically assisted treatment for recovery from opioid abuse, methadone 
clinics provide other rehabilitation services such as counseling and welfare services (Bell, Burrell, 
Indig, & Gilmour, 2006).  
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Factors that Influence Medically-Assisted Treatment Outcomes  
Risk Factors. Given the heavy consequences when addicts do not seek or complete 
treatment, it is important to have an understanding of the factors that affect their matriculation to 
and through treatment. As reviewed by Gyarmarthy and Latkin (2008), risk factors against 
beginning and completing treatment include lack of motivation, homelessness, continuous 
substance use, child care barriers, transportation barriers, and severe depressive symptomology. 
Emotional issues, interpersonal relationship challenges, and unsupportive social networks and 
environments are also risk factors for treatment attrition (Booth, Cook, & Blow, 1992; Curran, 
Kirchner, Worley, Rookey, & Booth, 2002; Doumas, Blasey, & Thacker, 2005; FalsStewart & 
Lucente, 1994; Haller, Miles, & Dawson, 2002; Luo, Pang, Wu, Mi, Wang, Li, 2007; Ravndal & 
Vaglum, 1994; Roffman, Klepsch, Wertz, Simpson, & Stephens,  1993; Williams & Roberts, 1991; 
Yang, Lin, Long, He, Li, Liu, Wang, 2008).  Brorson et al. (2013) revealed that the most consistent 
risk factor across the reviewed studies was younger age. Other frequent risk factors included 
cognitive deficits, low treatment alliance, and personality disorder; but findings around these 
variables has mixed outcomes in the literature. 
Protective Factors. Protective factors of treatment effectiveness, on the other hand, 
include being an intravenous user, being female, an older patient, previous attempts to rehabilitate, 
having a higher education, having a small drug using social network, HIV positive status, ethnic 
community membership, and religious group membership  (Appel, Ellison, Jansky, & Oldak, 
2004; Beardsley, Wish, Fitzelle, O’Grady, & Arria, 2003; Booth, Corsi, & Mikulich, 2003; Curran 
et al., 2002; Laudet, 2003; Schutz, Rapiti, Vlahov, & Anthony, 1994; Levin, Evans, Vosburg, 
Horton, Brooks, & Ng, 2004; Shah Celentano, Vlahov, Stambolis, Johnson, Nelson, et al., 2000; 
Stevens-Watkins, Perry, Harp, & Oser, 2012; Vaughn, Sarrazin, Saleh, Huber, & Hall, 2002).  
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Maintained contact with their families or having a permanent residence of the family are 
highly supported protective factors for recovering addicts. According to Stanton’s (1997) review, 
it has been long established that substance abusers reside and rely on their family members. Studies 
have shown that ranges between 40 to 90 % of substance abusers lived with their family members; 
mostly mothers, grandmothers, and sisters (Perzel & Lamon, 1979; Vaillant, 1966). Ross (1972) 
discovered that many addicts had a drug related address and a family related address. When it was 
time to provide emergency contact information, patients often provided a parent or relative’s 
information. Goldstein, Abbott, Paige, Sobel, and Soto (1977) hypothesized that having a 
household, in most cases a parent’s household which addicts can always go to, serves as a point of 
reference for those in recovery. These households are often the stability in a world and lifestyle 
that lacks stability. Stanton (1982) found that about 86% of their approximately 700 patients, saw 
their parent(s) on a weekly basis in a face-to-face setting. Daily telephone contact with a parent 
was made with 64% of the heroin addicts in research conducted by Perzel and Lamon (1979). The 
percentages for familial contact correlate with younger adulthood (ages 18 to 35), but is a pattern 
seen through various age cohorts (Perzel & Lamon, 1979; Stanton 1982; Vaillant, 1966). Stanton’s 
review also substantiated that addicts living with their parents is a phenomena internationally. 
Percentages within this pattern include: England—62%; Italy—80%; Puerto Rico—67%; 
Thailand—80 % (Stanton, 1982). 
Other protective factors once in rehabilitation are treatment completion or the length of 
stay in treatment. Mulder, Frampton, Peka, Hampton, and Marsters (2009) determined that patients 
who were in substance abuse treatment for at least three months did better in the program and had 
a greater reduction of drug use. They found that those who had a better mental health status at 
baseline, a higher prevalence of lifetime depression, less stimulant dependence, as well as a higher 
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sedative dependence were more likely to remain in the program for at least 3 months. The Drug 
Abuse Treatment Outcome Studies (DATOS) project produced similar findings to that of Mulder 
and colleagues (2009). The National Institute of Drug Abuse (NIDA) conducted a national 
evaluation of substance abuse treatment effectiveness for those over the age of 18. The evaluation 
included 96 community based programs from 11 cities. Over the two year evaluation there were 
over 10,000 patient admissions that were included in the assessment. They established that 
consistently across all treatment programs that patients who received three or more months of 
treatment had the greatest degree of drug use reduction (Hubbard, Craddock, Flynn, Patrick, 
Anderson, & Etheridge, 1997). When NIDA conducted a one year follow up to the DATOS study, 
they assessed approximately 3,000 patients and examined the treatment facility modality in regards 
to treatment efficacy.   In consideration of patients treated through an outpatient methadone clinic, 
those who were currently in treatment used heroin less frequently compared to those who dropped 
out. For those in outpatient drug free programs and long term residential programs, at least 6 
months of treatment enrollment was associated with drug use reductions. Long term residential 
patients, specifically, saw reductions in crime related activity and an increase in full time 
employment (Hubbard et al., 1997).  
A literature assessment conducted by Brorson and colleagues in 2013, revealed that the 
actual treatment completion was most associated with positive outcomes after treatment. Their 
review included almost 200,000 patients derived from a total of 122 studies conducted over the 
past 20 years. According to their review, most studies examined demographic variables of patients 
in relation to treatment outcomes, and reported that because of the current saturation in the 
literature any more studies on demographic variables would be of little value. They encouraged 
future researchers, alternatively, to examine the treatment programs, the focus of the treatment, 
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and the treatment processes to continue to assess risk factors of treatment attrition. (Brorson et al., 
2013). 
Gender Specific Factors. In regards to gender specific pre-cursors, women who have 
previous sexual or physical abuse, comorbid mental health presentations, and undiagnosed mental 
illnesses are susceptible of not entering or completing treatment (Dodge & Potocky, 2000; Kang, 
Magura, Laudet, & Whitney, 1999; Newmann & Sallmann, 2004). Gender specific literature 
reviews of 280 substance abuse articles revealed that women with substance abuse history are less 
likely to enter treatment compared to men. Aside from this finding, there were no other salient 
gender based differences regarding treatment retention, completion, or outcomes in this study. 
History of abuse was not related to treatment outcomes for either gender, but was related to positive 
drug screens for women and not for men (Messina, Wish, & Nemes, 2000). Domestic violence 
victimization was related to hours in treatment for men but not for women (Green, Polen, 
Dickinson, Lynch, & Bennett, 2002). However, treatments that focused on shared issues of women 
in recovery have shown some signs of greater effectiveness (Greenfield, Brooks, Gordon, Green, 
Kropp, McHugh, Lincoln, Hieng, & Mieleh, 2007). Work from Cocozza, Jackson, Hennigan, 
Morrissey, Reed, Fallot, & Banks (2005) found that for women mental health status, lifetime and 
current exposure to interpersonal abuse and other stressful events predicted treatment intervention 
outcomes. Compared to typical substance abuse treatment modalities, the comprehensive trauma 
informed service improved mental health systems as well as brought about a reduction in drug use. 
Data shows that compared to men, drug abuse treatment is more effective for women when they 
are seeking both mental health and substance abuse treatment (Fiorentine, Anglin, Gil-Rivas, & 
Taylor, 1997; McKay, Rutherford, Cacciola, Kabasakalian-McKay, & Alterman, 1996; Schuckit, 
Daeppen, Tipp, Hesselbrock, & Bucholz, 1998; Simpson & Tucker, 2002; Tate, Mrnak-Meyer, 
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Shriver, Atkinson, Robinson, & Brown, 2011). Other studies examining the benefits of increasing 
mental health counseling along with substance abuse found that in a population of Black, Hispanic, 
and White opioid addicted populations that pretreatment motivation, program engagement, and 
therapeutic relationship presented as the most salient predictors of effective treatment (Simpson, 
Joe, Rowan-Szal, & Greener, 1997).  
As noted, there has been a call among substance abuse experts to bring consistency to the 
substance abuse treatment evaluation literature (Brorson et al., 2013, Bühringer, Kraplin, & 
Behrendt, 2012; Tiffany, Friedman, Greenfield, Hasin, & Jackson, 2012; Donovan, Bigelow, 
Brigham, Carroll, Cohen, Gardin, Hamilton, Huestis, Hughes, Lindblad, Marlatt, Preston, Selzer, 
Somoza, Wakim, & Wells, 2012). Tiffany and colleagues (2012) noted almost 25 different 
treatment outcomes evaluated in the literature. These authors highlighted that these varied 
treatment outcomes will make it difficult to consolidate the literature to provide clear and succinct 
information about how to treat this population and monitor if the treatment has been effective. The 
authors supported measures of drug use as an assessment of treatment quality, but suggested that 
comprehensive treatment evaluation must extend beyond drug use. They proposed that patients are 
not in recovery because of the drug use itself, but more so due to the consequences of substance 
use in their social environments. Upon reviewing the substance abuse treatment evaluation 
literature, they produced five outcomes that had the soundest empirical support to continue using 
within the field. Those five factors included self-efficacy, cravings, quality of life, psychosocial 
functioning, and social network/social support. Self-efficacy is a unique outcome variable as one’s 
belief in their ability to make behavioral and life style changes is the foundation of substance abuse 
rehabilitation (Tiffany et al., 2012). Having a strong comprehension of opioid use and treatment, 
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the relevant terms in the literature, the risk and protective factors, as well as the future directions 
of the literature will be beneficial in understanding the merit of this research project.  
 
 
 
Literature Review 
Family Systems Theory  
When examining how familial relationships influence treatment outcomes in a medically 
assisted treatment population, knowledge about family systems theory and attachment are 
fundamental. Family systems theory is a prominent clinical conceptualization used by a variety of 
researchers and clinicians. This theory views families as a system, and the individuals within it as 
smaller units or parts of the system. Within this theory is the concept of circular causality, which 
posits that each individual within the system affects the functioning of the other individuals, and 
the functioning of the entire system (Day, 2008). The relationships among these individuals also 
affect the family’s functioning (Nichols & Schwartz, 2004). Family system theorists are 
proponents for assessing and treating the familial system in which the identified patient is a part 
of, in order to make an effective change (Day, 1995). Understanding the family system involves 
identifying the structure of the family. The family structure outlines the family expectations. These 
expectations are well understood by each member of the system, and can be recognized through 
the family’s interpersonal patterns (Nichols & Schwartz, 2004). One person’s behavior could be 
the product of relationships within the family that have been set by family expectations and rules. 
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Rules are set by boundaries, which are barriers that regulate family and unit level interactions. 
Systems theory focuses on the inputs and outputs of the system, thus there is a lot of attention 
given to communication styles and the behavior of the family (Nichols & Schwartz, 2004). 
Communication and behaviors are set by rules that are both explicit and implicit within the system 
(Day, 2008). These expectations set into familial norms over time. Children understand their 
family’s norms through examples from their adult caregivers (Day, 2008). Families respond with 
resistance when confronted with any threats to the stability of the family norms, which is 
characterized as family homeostasis (Day, 2008; Nichols & Schwartz, 2004). Individuals and the 
relationships between them (subsystems) are conditioned through experiences with the family. 
These subsystems could be pairings characterized as healthy, ally-based relationships or unhealthy 
conflict-based relationships. Another common subsystem is the triangular subsystem. Triangular 
relationships involve two family members whose relationship is strengthened by bonding over or 
out casting a third member of the family (Day, 2008). In unhealthy family subsystems it becomes 
very easy for the allied subsystems to focus on negative issues that may arise with another member 
of the family. Consequently, these subsystems give little to no resources towards addressing 
underlying chronic issues that are present in the family system (Nichols & Schwartz, 2004).  
Attachment 
A fundamental concept that overlaps with family systems is Bowlby’s Attachment Theory. 
Attachment, as defined by Bowlby (2005), is the behavior that obtains a desired proximity to 
another person. He establishes that relationships within families are all based on attachment. The 
person of interest within the attachment theory is noted as the attachment figure and is most often 
a parent or the person in the parental role. The attachment within the parent-child relationships 
begin while the child is an infant; and the remnants of their attachment style are present far into 
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adulthood (Bowlby, 1973). Healthy attachment styles are characterized as secure attachments, 
where there is a maintained bond with an attachment figure. Secure attachments provide 
relationships that allow emotions to be expressed in a way that feels safe and supportive (Nichols 
& Schwartz, 2004). Unhealthy attachment styles are brought about when there was no identified 
attachment figure or when the relationship with the attachment figure was not a secure relationship. 
These individuals often question their attachment figures and relationships in their life, lack 
confidence, and feel insecure about the safety of their world and environments. Specifically, it 
feels unsafe for them to express true emotions, due to the fear of being vulnerable, and thus they 
usually respond with anger, protest, or withdrawal (Nichols & Schwartz, 2004). As noted in family 
systems theory, foundational attachments establish expectations of how to interact in future 
relationships. This is especially true in regards to beliefs about supportiveness and the ability to 
create new healthy attachments. Thus, attachments equip individuals with schemas of themselves 
and others that navigate their interpersonal relationships into adulthood (Doumas, Blasey, & 
Mitchell, 2007). 
Attachment Styles. Attachment styles are further understood by attachment categories: 
secure, anxious-resistant/ambivalent, anxious-avoidant and disorganized (Ainsworth, Blehar, 
Waters, & Wall, 1978; Main & Hesse, 1990; Main & Solomon, 1990). Secure attachment styles 
are categorized as safe relationships, where the child feels secure and knows that their attachment 
figure will be responsive to their needs. Those who developed anxious attachment styles, usually 
had relationships with attachment figures who had low caregiver sensitivity. Anxious-resistant 
relationships are described as those where the child wanted to be close to the attachment figure, 
but had a caretaker who was low in knowledge and understanding of the needs of their children 
(Sroufe, Egeland, Carlson, & Collins, 2009). These ambivalent relationships show a child reluctant 
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to leave the presence of the caregiver, but resistant during attempts of interaction from the 
caregiver (McLeod, 2008). Anxious-resistant children are not easy to comfort during the 
attachment figure’s attempt at responsiveness, which is attributed to the inconsistent levels of 
responsiveness to the child. Anxious-avoidant attachment styles are notably characterized as 
children who actively ignore their attachment figures. This is consequential of caretakers who 
seem to lack affection and interest in the child, rejected physical contact, and are low in 
responsiveness (Sroufe et al., 2009). As these children develop they no longer seek their 
attachment figures during their times of distress, as their figures have proven to be unavailable for 
comfort. Anxious-avoidant individuals become independent of their attachment figure physically 
and emotionally (Behrens, Hesse, & Main, 2007). The fourth type of attachment style is the 
disorganized attachment pattern. Attachment figures of these types of children display incoherent 
behavior, where interactions with the caretaker is seen as confusing or the caretaker is seen as a 
threat (Sroufe et al., 2009). These children received maltreatment in the form of chronic emotional 
availability, from a figure that was insensitive and intrusive (Carlson, 1998). Children with 
disorganized attachment usually seem in conflict, as they constantly desire to flee both away and 
towards their caregiver. These insecure attachments often result in psychological pathology in later 
development (Sroufe et al., 2009).  
Adult Model of Attachment. These attachment categories were later developed into an 
adult attachment model by Bartholomew and Horowitz (1991). This model assessed the 
intersections of the individual’s perception of self and perceptions of others. According to 
Bartholomew’s and Horowitz’s (1991) model, those who developed a positive view of themselves 
as well as a positive view of others, become securely attached individuals. They are able to operate 
on their own and are comfortable with intimacy. Individuals who formed a negative self-view, but 
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maintained a positive self-view of others are conceptualized as having a preoccupied style of 
attachment. This type of attachment shows a preoccupation with relationships, where the person’s 
self-value is contingent on how others view them. This adult attachment style is consistent with 
the anxious-resistant/ambivalent category (Bartholomew & Horowitz, 1991). The third quadrant 
of the adult attachment model results from the avoidant attachment style, where the person has a 
negative view of themselves and a negative view of other people. These fearful-avoidant 
individuals overall feel unlovable and expect to be rejected by others. They respond to their fear 
by being socially avoidant, in order to protect themselves from actualized rejection. The fourth 
kind of adult attachment according to Bartholomew and Horowitz (1991) also derives from 
avoidant attachment styles, in which the person has a positive view of self but a negative view of 
others. Labeled as dismissive, they feel that they are worthy of love but have a negative disposition 
towards others. This disposition makes them less vulnerable, thus less likely to be disappointed in 
relationships.  They do not fear intimacy, as do fearful-avoidant types. They dismiss intimacy and 
operate in a realm of interpersonal independence. 
Attachment and Trauma. Trauma greatly affects attachment styles due to the mistrust of 
attachment figures or other figures, and becomes a barrier for developing secure attachments with 
those figures or in one’s future relationships (Allen, 2001). Maltreatment experienced in 
developmental relationships affects ones view of others and view of self. This results in great 
difficulty in understanding how to properly get one’s emotional needs met (Charuvastra & Cloitre, 
2008). These individuals tend to have a smaller interpersonal network, because this mistrust leads 
them to behave in ways that push others way (Min, Tracy, & Park, 2014). 
Conceptualization of Families and Addiction. Steinglass’s (1989) research argued that 
substance abuse should be conceptualized in the context of family systems. He identified that 
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substance abuse is chronic in nature, thus understanding addiction in the context of the family will 
help decipher what contextual mechanisms are in place to perpetuate the addiction. The presence 
of the drug in the system of the addict, allows the substance to become present in the system of the 
family as well. When an identified patient is under the use of an illicit substance, this alters how 
they interact with others. Additionally, given that addiction is cyclical, it is possible to observe the 
family amidst and in between the patterns of drug intoxication. The family develops behavior 
around these patterns, and the family’s behavior becomes scripted and predictable (Stelle & Scott, 
2007). The addict of the family is a symptom of the family dysfunction, thus this person plays a 
major role in the family narrative. They allow the family to become a problem determined system, 
where everyone shares the idea that a particular issue or person is the problem of the family 
(Anderson, Goolishian, & Windermand, 1986).  This removes any focus that could be placed on 
other members’ anxieties or attention that could go onto the family’s underlying dysfunction 
(Papero, 1995). Addiction has a developmental trajectory of growth and maintenance, as do family 
systems, which allows addiction to fester in the family over time (Stelle & Scott, 2007). 
There are rules that govern the family system of an addict. Explicit rules for children are 
either nonexistent, unpredictable, or strict. However, implicit rules do exist. It is clearly understood 
that the addict’s drug use is the most important mechanism sustaining the family’s system. All 
family members are to recognize that the addict’s behaviors are not addict’s fault and that the 
substance use did not cause the family’s issues. Thirdly, every family member must play a role in 
enabling the disease, to uphold addiction as it is the focal principle of the family’s system. In order 
to maintain this system, family members are not allowed to talk about their feelings or the 
addiction, trust their feelings or each other, nor are they allowed to have any feelings at all. By 
limiting conversation about the disease, this sustains the system, which is important for the family 
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structure (Brooks & Rice, 1997). These maintenance mechanisms can still be in play if family 
members are solicited to assist the addict with recovery. Recognizing these mechanisms may not 
only benefit treatment outcomes but could assist in preventing these maladaptive patterns from 
being passed on to future generations.  
It is vital to fully recognize how the family, attachment styles, and addiction interact with 
one another. Individuals with insecure attachment styles experience greater difficulty with 
separating their behaviors and cognitions from family processes. Thus, they are less likely to 
understand how their family processes contribute to their behaviors and cognitions in regards to 
substance use. Subsequent of this unawareness, they are more likely to re-enact these dysfunctional 
familial patterns and develop substance addiction. A part of the focus of substance abuse treatment 
is to illuminate these processes to patients (Zweben, 1991). 
Turning to substance abuse is a realistic fear for some children of these addicted systems. 
There are children of addicts who are concerned about a predisposition of dependency, and are 
even more concerned about passing this trait to their own offspring (Worthington, Scherer, & 
Cooke, 2006). They are fearful of the true possibility that addiction will continue through their 
family system (Ackerman, 1983). However, for other children in addicted families, coping through 
substance abuse is a natural progression. According to Worthington Scherer, and Cooke (2006) 
the substance abuse literature identifies five ways that children of addicts begin using. It is likely 
that the children of addicts begin to adopt their parents coping strategies and behaviors (Chassin 
& Ritter, 2001; Kilpatrick Acierno, Baunders, Resnick, Best, & Schnurr, 2000), there are illicit 
substances available in the home, these children developed resentment towards their parents for 
neglect or not protecting them, there was low parental monitoring providing more opportunity to 
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experiment with substances, or they are coping with being the objects of abuse (Windom & Hiller-
Sturmhofel, 2001).   
Families in addiction are housed in a larger community systems, which in some ways can 
and does contribute to the addiction. In many cases, patients struggling with addiction come from 
low-income communities. These adults have seen generations of poverty stricken and powerless 
family members, and experience a sense of helplessness as a result (Mikesell, Lusterman, & 
McDaniel, 1995). In addition to environmental stressors such as poverty, crime, and low access to 
resources that would sustain a moderate quality of life, these families also have to manage how 
culture affects their family system. Coping with societal stereotypes and discrimination from race 
and ethnic minority membership, social class standing, and gender stereotypes also impact the self-
esteem and self-efficacy of those who live in these environments (Brooks & Rice, 1997; Menicucci 
& Wermuth, 1989). 
Family Based Interventions 
Given the familial influence on the addict’s recovery, many researchers and clinicians have 
sought to include families in treatment, in order to improve substance abuse treatment outcomes. 
Brown (1985) defined addiction as a family disease. She states that “all family members suffer the 
consequences of one member’s addiction, and all play a role in maintaining the destructive 
interactional patterns that result from addiction” (pg. 235). Whether the disease is sustained by 
providing the substance of choice, causing distress for which substance abuse is used to cope, or 
by doing nothing but accommodating it in the family system, all family members contribute to 
addiction. Given this realization, family members are thus equally important in the treatment of 
the disease. Family members can positively influence recovery in that they could be encouraging 
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and engaging in positive activities with the identified patient. Research shows that support from 
families who get along well decrease the likelihood of relapse (Ellis et al., 2004). However, 
families that are low on cohesion, high in conflict, produce a stressful environment, or are 
substance abusers themselves increase the likelihood of relapse for an identified patient (Ellis et 
al., 2004; Rhodes & Jason, 1990). When familial social support is not adequate, this is attributed 
to families having a lack of education about the importance of their role during the recovery 
process (McAlpine, 2013).  In the case of families with an identified patient addicted to heroin, 
there is evidence that their family systems differ from other dysfunctional families (Stanton, 1978). 
Common characteristics of these families include generational addiction, prenatal exposure to 
heroin, and social networks around the family who are drug users. These families are often 
differentiated with marital problems between the mother and father. The father figure is usually 
distant, the mother is overinvolved with the children, and the children begin to engage in substance 
abuse as a form of attention seeking (Stanton, 1978). For clinicians, if a methadone patient is the 
product of an opioid addicted family system this could provide an informative background around 
the family’s influence on addiction, and subsequent potential treatment outcomes.  
Although the negative presence of family members can prove challenging for recovery, the 
presence of positive family members in the lives of recovering addicts has shown to be 
indispensable. When a part of the recovery process, families communicate their values, strengthen 
attachments, and provide needed support (Rhodes & Jason, 1990). Families can provide tangible 
support such as a place to live while in recovery, or they can demonstrate the worth of the 
individual to the family through emotional support; both of which improve substance recovery 
behaviors (Booth, Russell, Soucek, & Laughlin, 1992; Tracy, Munson, Peterson, & Floersch, 
2010). Lloyd and colleagues (2005) found that addicts who lived with family members were about 
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three times more likely to enter methadone treatment. Replacing a social network of drug users to 
positive family members is recommended by the substance abuse researchers as it predicts better 
treatment outcomes (Ellis et al., 2004). A review conducted by Stanton (1997) showed that the 
benefits of family involvement in recovery include high commitment to family therapy, lower 
dropout rates compared to other psychotherapy treatment modalities (Edwards & Steinglass, 1995; 
Liddle, 2004), improved treatment effectiveness, decreased problems associated with addiction 
(Lin, Wu, & Detels, 2011; Peters, Pontin, Lobban, & Morris, 2011), and the patients feeling that 
they were better partners and family members (Marshall, Kimball, Shumway, Miller, Jefferies, & 
Arredondo, 2008). The success of the family interventions on treatment are attributed to gender 
factors, relationship investments, and perceived social support from an abstinent family member 
(Edwards & Steinglass, 1995; Stanton & Shadish, 1997).  
For those who include their families in their rehabilitation, they include their parents or 
their parental figures as a part of their social support network in family therapy (Salmon, Joseph, 
Saylor, & Mann, 2000). Adult siblings are often involved, especially if childhood relationships 
were described as warm and chose. Siblings who had relationships with the identified patient that 
were high in conflict or high in indifference, were usually less obligated to be a part of family 
based interventions (McAlpine, 2013). Spousal support is highly valued and very prevalent in 
substance abuse recovery. Kidorf, King, Neufeld, Stoller, Peirce, and Brooner (2005) identified 
that spousal involvement in addiction treatment enhances treatment adherence, reduces substance 
use, improved spousal relationships, and maintained drug abstinence after treatment. The literature 
heavily substantiates a relationship between family support and relationships to treatment 
outcomes, for families high in cohesiveness and those low in cohesiveness.   
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Relationship Quality  
As noted, relationships in between family members are just as influential to the family 
system as the members themselves (Day, 2008; Nichols & Schwartz, 2004). Healthy relationships 
exist where a loved one is predictable (Ainsworth et al., 1978). Negative relationships, on the other 
hand, may serve some minimal functions; however if the necessary emotional support is not 
present then the relationship is not healthy. Consistency, nurturance, empathy, and bonding are all 
elements for a healthy relationship (Ainsworth et al., 1978; Bowlby, 1958; Stern, Hofer, Haft, & 
Dore, 1985). Relationship quality stems from the perception that one is understood by, valued, and 
supported by the person with whom they have a relationship with (Reis, Clark, & Holmes, 2004). 
High relationship quality is characterized by one’s satisfaction with the commitment and affection 
within the relationship. Low relationship quality is influenced by a person’s ability to regulate their 
affect (Martini & Busseri, 2012). Those who are recovering from addiction, may be struggling to 
forgive or accept themselves, and often experience shame and guilt (Worthington, 2013). These 
addicts often inflict pain on those around them, which decrease the quality of their relationships. 
As a result, the addict’s supporters may have a difficult time providing their continued support 
(Worthingon, Scherer, & Cooke, 2008).   
The family’s adaptability and cohesion have been strongly associated with one’s perception 
of relationship quality with their family members (Costantini , Wermuth, Sorensen, & Lyons, 
1992), as well as support in times of high need (Dickerson & Crase, 2005). The construct of 
relationship quality is unique as it is relevant irrespective of the number of social supporters. This 
is demonstrated in a study by Min, Tracy, and Park (2014), showing that recovery from trauma 
was not related to the amount of social supporters of recovery, but that the quality of the 
relationships between the addict and their supporters led to greater recovery.  
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Negative Relationships. Many unhealthy relationships are portrayed with anger, fear, 
shame, and guilt, where a loved one is not predictable. Environments characterized with anger and 
fear, produce children who are not allowed to display this anger or any type of affect (Brooks & 
Rice, 1997). However, these feelings do not dissipate, instead these emotions manifest themselves 
in behaviors overtime. Parental transgressions experienced during their childhood can result in 
unforgiving feelings, and can also produce anger and fear (Worthington, Scherer, & Cooke, 2006). 
Children are further dejected in homes where they are taught to feel shame and guilt around the 
family’s experiences and private matters. Shame comes with feelings of isolation and alienation 
from others. Brooks and Rice (1997) postulated that shame is used to control, manipulate, and 
destroy someone. Those who wish to gain power and control over others will try take to control of 
a lesser powered party through shaming them. An individual’s social shame combined with their 
family’s shame creates a toxic environment for the offspring of drug addicts. Negative 
relationships can be developed in the home as a result of the child experiencing feelings of grief 
or loss towards a parent who is physically present but not emotionally present. This is the case in 
situations when the parent is preoccupied with over parenting or tending to an addicted spouse, 
and the parent is subsequently neglecting their child caretaking duties (Brooks & Rice, 1997). 
There are significant mental health consequences for children who are developing in 
neglected environments who encounter mental, emotional, and at times physical abuse. These 
children experience an increased amount mental illness diagnoses, use more outpatient treatment 
services, have a higher number of psychiatric hospitalizations, and greater instances of drug abuse 
(Greenfield et al., 2007). Consequences of negative relationships go beyond mental health, and 
have been associated with outcomes including higher BMI as well as heart disease (De Vogli, 
  
 
23 
 
Chandola, & Marmot, 2007; Kouvonen, Stafford, De Vogli, Shipley, Marmot, Cox, Vahtera, 
Vaananen, Heponiemi, Singh-Manoux, & Kivimaki, 2011; Krause, 2005).   
The consequence of growing up in a family system with negative relationships is the 
possibility of developing negative relationships outside of the biological family. A major relational 
unit impacted by the presence of addiction, is the relationships between partners and spouses. Most 
couples, regardless of addiction status, fall into one of three conflict styles: they either avoid or 
minimize their problems, they are validating and solution oriented, or they are volatile by actively 
and passionately disputing each other (Gottman & Levenson, 2000). When one or both partners 
are engaging in substance abuse this exacerbates their conflict style as a couple. It is not 
uncharacteristic of opioid abusing patients to be uninvolved or in unstable relationships 
(Kauffman, 1985; Kidorf, Brooner, & King, 1997). This could be another one of the many 
consequences of substance abuse, especially when difficulty with emotion regulation was present 
prior to addiction. Unhealthy partnerships riddled with addiction of one or both partners, often find 
one partner purposely intervening with recovery of the other (Thomas, Yoshioka, Ager, 1996).  
Negative relationships affect members of the family system of all ages and at different subsystem 
levels. The impacts of the relationships can be seen in psychopathology and substance use, and can 
influence substance use treatment. 
Social Support 
Social support is another heavily cited construct that influences treatment outcomes in 
addiction populations. Social support is defined by four constructs presented by Gottlieb (1983) 
and Barrera and Ainlay (1983). Social support encompasses receiving verbal or nonverbal 
information or advice, tangible aid, or a behavior that includes one’s physical presence. These 
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constructs must have perceived emotional and behavioral benefits to be considered support by the 
recipient (Brown & Riley, 2005; Tracy et al., 2010). A social support network (in the context of 
recovery) are the individuals and systems in place to reinforce efforts to obtain abstinence (Tracy 
et al., 2010).  
In regards to measuring social support, the concept is often broken down into smaller 
definitive constructs. Some theorists conceptualize social support as either structural (quantitative 
measure of the amount of resources available), or functional (the quality of actual or perceived 
instrumental and emotional support) (Beattie, Longabaugh, Elliott, Stout, Fava, & Noel, 1993; 
Brown & Riley, 2005; Goehl, Nunes, Quitkin, & Hilton, 1993; Huselid, Self, & Gutierres, 1991; 
Rychtarik, Foy, Scott, Lokey, & Prue, 1987; Strug & Hyman 1981). There are other theorists who 
consider the perceived quality of support separate from the functional concept, and conceptualize 
the quality of support as its own construct (Brown, Vik, Patterson, Grant, & Schuckit, 1995; 
Gordon & Zrull 1991; Humphreys, Moos, & Cohen, 1997). The concept of functional support is 
further broken down into informational support, emotional support, and tangible support (Tracy et 
al., 2010). 
Positive Social Support. Support was measured generally in a study by Salmon, Joseph, 
Saylor, and Mann (2000). The authors found that social support was increased once patients 
entered recovery, that there were inevitably some family and friends who doubted their recovery, 
and that social support was of value to them while they were working on their abstinence. Social 
support has proven beneficial for drug use, as social support networks will often highlight problem 
usage to the identified patient before an addiction is developed (Gyarmarthy & Latkin, 2008). 
Treatment entry, maintenance of behavioral change, lower rates of drug initiation, less illicit drug 
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use, fewer relapses, and successful alcohol and drug treatment outcomes were also associated with 
positive social support networks (Booth et al., 2003; Brown & Riley, 2005; Wasserman, Stewart, 
Delucchi, 2001). Length of time to readmission in substance abuse treatment was associated with 
perceptions of worth from the patient’s family (Booth et al., 1992). Perceptions of family pressure 
to enter substance abuse treatment was greater from spouses for older high-income adults, and 
greater from family members by those with lower incomes (Room, Matzger, & Weisner, 2004). 
Family supportiveness and cohesiveness have been associated with less drug, family, and 
psychological problems within the three months after treatment (Kelly, O’Grady, Schwartz, 
Peterson, Wilson, & Brown, 2010). There are also fewer relapse experiences when the family is 
involved with the recovery (Ellis et al., 2004; Kelly et al., 2010). The patient’s partner’s support 
of substance abstinence also predicted lower risk of substance abuse (Havassy, Hall, & 
Wasserman, 1991). Research on the relationship between functional social support and stress 
revealed that greater functional support was associated with reductions of stress during recovery 
(Dobkin, De Civita, Paraherakis, & Gill, 2002). 
The literature cites several benefits of social support which could be an advantage to those 
in substance abuse recovery. Social support has been linked to increased mental and physical 
health, longevity, and improved quality of life (Dobkin et al., 2002). Support has been found to 
buffer the deleterious effects of poverty and financial hardships, as well as crisis outcomes (Brown 
& Riley, 2005; De Maeyer, Vanderplasschen, Camfield, Vanheule, Sabbe, & Broekaert, 2011). 
Drug use has been found to vary based on social networks that are in the patient’s environment. It 
is important to acknowledge that while in recovery abstinence can fluctuate based on the context 
of the social support.  
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Negative Social Support. Given that addiction is a family disease (Brown, 1985), family 
members are influential to the recovery process.  Family discourse during and after recovery, as 
well as hostility and criticalness from partners can lead to relapse (Ellis et al., 2004; O’Farrell, 
Hooley, Fals-Stewart, & Cutter, 1998). Women found that interpersonal conflicts with partners 
and family members were typical precursors to relapse (Tracy et al., 2010). Women with trauma 
histories often had smaller social support networks and reported less relationship quality (Min, 
Tracy, & Park, 2014). In a focus group conducted by (Tracy et al., 2010), almost 30% of the women 
reported that they did not have a relationship with someone in their lives who would want to help 
them discontinue their drug use. In a study of women in methadone treatment by El-Bassel, Chen, 
and Cooper (1998), 18% of their social support networks were substance users and 10% of this 
social network provided drugs to them while they were in recovery. 
Not all social networks that provide social support will reinforce positive abstinence-based 
behaviors (Tracy et al., 2010). Some peers aid rehabilitation by giving a patient a place to stay or 
agreeing to watch their children. However, in the same instance they impede one’s recovery by 
offering a drink, a sniff, or a hit of one’s choice substance. The effects of having current drug users 
in one’s social network had a larger impact on treatment outcomes than did positive family support 
(Ribisl & Luke, 1993). Patients acknowledge that there is tension between their “recovery 
supportive” and their “substance use supportive” networks. Treatment outcomes were highly 
correlated with which networks patients spent the most time with (Ellis et al., 2004; Kidorf et al., 
2005). In order to support addiction behaviors, the drug supportive networks will provide free 
drugs, in an attempt to help the patient with drug costs (Gyarmarthy & Latkin, 2008). Challenges 
of accepting free drugs were especially salient for women who were low-income and had nothing 
tangible to give in return. Although providers encourage patients to sever ties with drug using 
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peers, they often enter new relationships with different drug users in their communities or at the 
rehabilitation clinics (Kelly et al., 2010). Conclusively, there is an overwhelming amount of 
support in the substance abuse literature substantiating that association with substance using social 
networks will negatively impact treatment and likely lead to relapse (Brown & Riley, 2005; 
Havassy, Hall, & Wasserman, 1991; Goehl et al., 1993; Gyarmarthy & Latkin, 2008; Rosen, 2004).  
Tangible Support. Those in substance abuse recovery share that negative social networks 
can affect recovery by providing unsupportive messages and being insensitive due to their lack of 
understanding of the treatment process (Tracy et al., 2010). However, these patients also regarded 
tangible support from negative social networks as very helpful. Tangible support is functional 
concrete aid (Gottlieb, 1983). Examples of tangible support include providing money, 
transportation, a place to stay, child care, or providing needed items such as clothes, blankets, 
shoes, cigarettes, stamps, and food (Tracy et al., 2010). Much of this type of assistance was highly 
valued, as in many cases this support was essential to receive treatment for their drug abuse (Moos 
& King, 1997; Tracy et al., 2010). However, treatment completion was predicted by perceived 
emotional support more so than tangible support from their family or governmental systems and 
social agencies (Tracy et al., 2010). This may have been because tangible support could also lead 
to negative influences on recovery. For example, if a patient felt that it was best to reduce 
interactions with a social support who is in their drug using network but this person babysits their 
children while they are at work, this produces a dilemma for the patient (Tracy et al., 2010).  
Social Isolation. Social isolation is a correlate of treatment attrition (Brorson et al., 2013). 
The fewer members in one’s social network, the higher the possibility of negative health outcomes 
(Brown & Riley, 2005). Certain populations have been found to be more vulnerable to social 
isolation. Older methadone users are noted to attribute their lack of trust as the reason for their lack 
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of interest in establishing and engaging with a social network. This mistrust stemmed from 
traumatic experiences and past maladaptive interpersonal relationships. This is consistent with 
literature that states social isolation from family especially, is indicative of severely damaged 
attachments affected by abuse (Panchanadeswaran, Johnson, Sivaram, Srikrishnan, Latkin, 
Bentley, ... & Celentano, 2008; Pearlman & Courtois, 2005).  Another population that leans to 
social isolation are women with trauma histories. Grella (2008) hypothesizes that this isolation 
stems from a combination of these women pushing social networks away, as well as networks 
pulling themselves back as they have found their chronic assistance to the patient cumbersome. 
Populations at risk of social isolation miss the opportunity to benefit from the advantages that 
come with a social network, especially in the context of recovery (Smith & Rosen, 2009). Kelly et 
al. (2010) shares that there are some benefits of having a smaller social network, in that this leaves 
these recovering addicts protected from additional negative influences.  
Self-Efficacy 
Self-efficacy is the belief that one has the ability to achieve a desired outcome (Bandura, 
1977; Bandura & Locke, 2003; Dolan, Martin, & Rohsenow, 2008). Per a review by Kadden and 
Litt (2011) self-efficacy has been employed to measure outcomes in education, sports, chronic 
medical conditions, work-related performance, psychosocial functioning, and health functioning. 
In regards to treatment outcomes for addictive behaviors, self-efficacy has been used to assess 
smoking, alcohol abuse, amphetamine use, cocaine use, and gambling (Baer, Holt, & Lichtenstein, 
1986; Burling, Reilly, Moltzen, & Ziff, 1989; Demmel & Rist, 2005; Feeney, Connor, Young, 
Tucker, & McPherson, 2005; Hodgins, Peden, & Makarchuk, 2004; Solomon & Annis, 1990).  
Several different measures have been created to assess self-efficacy in a variety of problem areas 
of specific substance abuse (Annis, 1982; Bach, Brown, & Barlow, 1999; Young & Wei, 1996).  
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Much attention has been given to self-efficacy as an outcome variable in substance abuse 
treatment research, as it has been shown to be more effective than global rating, psychiatric 
outcomes, and other general measures of successful treatment outcome (Annis & Graham, 1988; 
Sklar & Turner, 1999; Tiffany et al., 2012). Predictors and correlates of self-efficacy of treatment 
success in a substance abuse population include readiness to change, motivation, age, cognitive 
functioning, increased education, recent substance use,  less intense or lengthy past substance use, 
focus on treatment benefit, having or observing a series of successful recoveries, and being 
persuaded about the positive effects of abstaining. (Demmel, Beck, Richter, & Reker, 2004; Dolan 
et al., 2007; Majer, Jason, & Olson, 2004). Relapses and attrition in treatment have also been 
predicted by self-efficacy (Allsop, Saunders, & Phillips, 2000; Ilgen, McKellar, & Tiet, 2005; 
Maisto, Connors, & Zywiak, 2000). Self- efficacy has been found to be a predictor of performance 
levels, coping behavior, and resilience (Kadden & Litt, 2011). Depressive symptoms have been 
found to be associated with reduced self-efficacy (Abrams & Niaura, 1987; Dolan et al., 2007). 
Patients who are high in self-efficacy are more likely to attribute drug use while in recovery as a 
slip up, while patients who are low in self-efficacy are more likely to completely relapse (Bandura, 
1986). When conceptualized as an intervention target, self-efficacy was found to increase access 
to emotional and sobriety support from those in close relationships with the identified patients 
(Min, Tracy, & Park, 2014). Assessing self-efficacy is also essential in substance recovery because 
it has been found to serve as the mediating variable between treatment approaches and successful 
outcomes (Aase, Jason, & Robinson 2008; Litt, Kadden, & Stephens, 2005). In a comparison of 
five empirically supported mediators, self-efficacy emerged as the strongest in measuring outcome 
of substance abuse treatment (LaChance, Ewing, Bryan, & Hutchison, 2009). It is with little doubt 
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that self-efficacy is an important construct to include when examining the experiences of those in 
substance abuse treatment. 
Quality of Life 
Quality of life is defined as one’s overall wellbeing and perceived satisfaction in a variety 
of areas in their life. These domains of satisfaction include health related (i.e. physical, emotional, 
and cognitive health) and non-health related areas (i.e. social and professional roles) (Gill & 
Feinstein, 1994; Laudet, 2011; Laudet, Becker, & White, 2009; World Health Organization, 1948). 
Some substance treatment programs posit that improved quality of life is essential for recovery 
(Welsh, Buchsbaum, & Kaplan, 1993). One’s quality of life prior to their recovery is often lower 
because of issues such as incarceration, homelessness, family conflict, and untreated mental illness 
(Bellack & Gearon, 1998; Havassy & Arns, 1998; Rach Beisel, Scott, Dixon, 1999; Russo, Roy-
Byrne, Reeder, Alexander, Dwyer-O'connor, Dagadakis, ... & Patrick, 1997).  
Individuals with substance use disorders often have comorbid psychological issues. Due to 
this comorbidity, they may be more vulnerable to a lower quality of life (Drake, Mueser, & 
Brunette, 2007). When solely assessing the impact of substance use on quality of life, it has been 
found that maintained abstinence from substances considerably improves one’s quality of life 
(Picci, Oliva, Zuffranieri, Vizzuso, Ostacoli, Jaretti, & Furlan, 2014). Also, those who undergo 
treatment but do not achieve abstinence did not have a significant change in their quality of life. 
This is likely because relapses can cause greater distress and interfere with their treatment 
(Urbanoski, Cairney, Adlaf, & Rush, 2007). The severity of psychological distress, however, has 
actually been found to have a stronger effect on quality of life the than severity of substance use 
(Rudolph & Watts, 2000). It has been substantiated that psychological distress can lead to lower 
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quality of life, which can be further exacerbated by substance use (Urbanoski et al., 2007). For 
patients whose life satisfaction has been lowered by these comorbid issues, it has been 
recommended that they seek additional resources and support in order to achieve a greater quality 
of life. For example, many methadone programs acknowledge the needs of their patient population 
and aim to provide social, psychological, and occupational resources for their patients (Carpentier, 
Krabbe, van Gogh, Knapen, Buitelaar, & de Jong, 2009; Millson, Challacombe, Villeneuve, Strike, 
Fischer, Myers, ..., 2006; Vanagas, Padaiga, & Bagdonas, 2006). Methadone treatment has been 
found to improve quality of life by reducing patients’ drug use as well as related stressors 
(Maremmani, Pani, Pacini, Perugi, 2007; De Maeyer, Vanderplasschen, Lammertyn, van 
Nieuwenhuizen, Sabbe, Broekaert, 2011). 
As a variable of note, quality of life has been viewed as essential to assess one’s progress 
in treatment and creating successful treatment goals (De Maeyer et al., 2011; Lehman, 1988; 
Packer, Husted, Cohen, et al., 1997; Smith & Larson, 2003). It is also often considered a treatment 
outcome of interest for substance abuse studies (Karow, Verthein, Krausz, & Schafer, 2008; Malet, 
Llorca, Beringuier, Lehert, & Falissard, 2006; Picci, Oliva, Zuffranieri, Vizzuso, Ostacoli, Sodano, 
& Furlan, 2014). Understanding the improvement of patients’ quality of life in comparison to non-
substance using populations, has been found to be a good measure to determine treatment efficacy 
(De Maeyer, Vanderplasschen, & Broekaert, 2009; Ribeiro, 2010).  
To augment the benefits of abstinence provided by methadone treatment, other factors 
influencing quality of life are considered. There is a substantial amount of evidence that positive 
social support groups, especially those who can deter drug usage, are advantageous for one’s 
quality of life (Dobkin, De Civita, Paraherakis, & Gill, 2002; Garmendia, Alvarado, Montenegro, 
& Pino, 2008; Mizuno, Purcell, Dawson-Rose, Parsons, & Team, The S. U. D. I. S., 2003). 
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Essentially, individuals without necessary social support for their recovery, may have a lower 
quality of life. Those who are entering substance abuse treatment are more likely to attribute poor 
finances and inadequate living situations to their overall poor quality of life. In turn, they may need 
to rely on social support from family members for financial and housing support while they are in 
treatment (Bebout, Drake, Xie, McHugo, & Harris, 1997; Conroy, Kimber, Dolan, & Day, 2008; 
Information Services, 2007). Quality of life is an outcome of importance because it encapsulates 
factors that can lead to drug abuse prior to treatment and relapse after treatment. There is ample 
evidence that in order to sustain one’s recovery that their quality of life must be improved in 
conjunction with their treatment (Picci et al., 2014).  
Pathway from Insecure Attachment to Methadone Use 
Upon review of how family systems theory, attachment mechanisms, social support, self-
efficacy, and quality of life each contribute to treatment outcomes, it is essential to identify the 
unique developmental trajectory of the impact of family relationships to methadone treatment. 
Building on the attachment discussion, hundreds of studies have sought to examine the 
relationships between insecure attachments and psychopathology (Mikulincer & Shaver, 2007). 
As originally conceptualized by Bowlby (1958) many researchers theorize that disruptions in 
attachment and emotional capacity begin during infancy. Affect regulation and self-organization 
are facilitated by interactions with maternal figures during this nascent stage. When maternal 
figures are responsive, consistent and supportive, this benefits infant’s self-organization process. 
They imitate their mother figure’s affect while learning how to regulate their own. Disruptions in 
affect regulation and self-organization occur when the mother figure is unresponsive, inconsistent, 
or unsupportive when caring for the child. This affect deficiency can later exhibit itself in various 
forms of mental illness (Fonagy & Target, 2003).   
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This insufficient care from attachment figures then continue into toddlerhood. This is the 
period where the child begins to experience exploration and independence, while still having a 
great need for security and attachment. Essentially, they desire to create distance from their 
caregivers while still being close enough to maintain a feeling of safety. Through this period of 
seeking individuation the child aims to display their competency, which in healthy attachments is 
facilitated by reassurance and encouragement from their attachment figure (Brooks & Rice, 1997). 
Toddlers whose attachment figures provide incompetent care or are over bearing of the child are 
not able to master their doubts and insecurities during this stage. Children at this age undergo “trial 
and error” exploration of their world and relationships, and are able develop a sense of “good and 
bad.” During this stage, they are socialized into the larger world, learning how to share, to regulate 
their bowels, and to use their words instead of throwing tantrums. This independence can be 
intimidating and bring about anxiety in toddlers. They need routines to have predictability and to 
understand that the new world they are exploring is safe. Anxiety is also consequential of this 
period while trying to understand right and wrong in order to please their caregivers (Brooks & 
Rice, 1997).  
Toddlers who have poor attachments with their parental figures are not able to master their 
doubts and insecurities. Despite their frustrating transitional period, they may get cues from their 
attachment figures that the expression of emotions is wrong; leaving them confused about the 
proper way to express their affect (Brooks & Rice, 1997). Consequentially, problems in emotional 
development occur, and they may get stuck during this period of development instead of moving 
successfully to the next stage of individual growth. Toddlers who matriculate successfully from 
this stage develop frustration tolerance, increase individuation, and are able to integrate the good 
and bad aspects of their attachment figures as well as themselves (Isaacson, 1991).    
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The next stage in development are the preschool years. This period is characterized with 
difficulty differentiating between fantasy and reality, inaccurate or illogical conclusions, and 
feeling that they are at the center of the world where everything that does (and does not) happen 
are consequential of their doings. A healthy relationship with the attachment figure helps them 
make sense of their curiosities and experiences. As evidenced in role play during playtime with 
peers, children imitate and emulate what they see adults do. When children are expressing angry 
emotions, examples of patience, tolerance, guidance, and modeling from the attachment figure can 
guide the child towards a healthier expression of anger. During this stage, children want to be 
adults but understand that their bodies are not big enough to engage in adult tasks. This frustration 
also needs assistance being regulated by adult guidance (Brooks & Rice, 1997).  
Children who have poor attachment with their caregiver easily develop a sense of “false 
self,” which is who they believe their attachment figure would like them to be. They initiate 
behavior but are constantly focused on the response from their environment, this then causes a 
separation between their cognition and their affect. Given that illogical thinking is characteristic 
of this stage of development, when there is an inadequate cognitive facilitation from a caregiver, 
children do not properly develop out of this developmental stage, and their illogical thinking 
continues (Brooks, 1997; Isaacson, 1991). 
Negative attachments with parental figures can lead to unsuccessful development out of 
the infancy, toddlerhood, or preschooler stages, and can have many psychosocial consequences. 
Poor affect regulation skills and lack of proper adult guidance can manifest in low self-esteem, 
problems in self-identification, deficient impulse control, poor ego functioning, or inability to 
reality test. These lead to intensified feelings of anger, depression, shame, and guilt (Isaacson, 
1991; Khantzian, 1997; Levin, 1987). Defenses against these negative affective states include rage, 
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isolation, denial, rationalization, projection, and emotional splitting. Dysfunctional families with 
low intimacy and little opportunities to express anger, create deeply rooted pain that can lead to 
psychopathology, trigger substance use, and addiction later in development (Brooks & Rice, 1997; 
Isaacson, 1991; Khantzian, 1997; Levin, 1987).   
Concerns about substance abuse and addiction become problematic during adolescence. 
This is the stage when the individual begins to engage in more intense relationships outside of the 
primary family system. They are still exploring their world, but are doing so within the context of 
peer relationships. The literature shows that parent-child attachment has a relationship with earlier 
onset of substance abuse (Kosterman, Hawkins, Guo, Catalano, & Abbott, 2000).  As products of 
poor attachment relationships with parental figures, these individuals are usually seeking to 
manage pain and frustration from their ill-completion of previous developmental stages. During 
this period, adolescents are exposed to experiments of substance use by their peers (Steinberg, 
Fletcher, & Darling, 1994). Unknowingly to them, they seek substances that fill the emotional void 
that they are experiencing (Khantzian, 1985).  
Application of the Self-Medication Hypothesis. The Self-Medication Hypothesis 
proposed by Khantzian (1985), conceptualizes drug use as a match between the physiological 
needs subsequent of one’s affect with the substances’ psychopharmacologic properties. 
Individuals use drugs as a defense against unwanted feelings and to embrace emotions that are 
usually suppressed due to emotional defenses (Khantzian, 1985). The Self-Medication Hypothesis 
elucidates why some individuals transition from substance use to substance abuse. Given their lack 
of affect regulation, substance abusers are able to use substances to cope with their specific 
experience of emotional distress, and obtain psychological stability. The ability for the emotionally 
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distressed person to regulate their affect is appealing, and an experience that they want maintained 
(Khantzian, 1997; Schindler, Thomasius, & Petersen Sack, 2009). 
There are an array of substances hypothesized under the self-medication model that address 
the particular socioemotional needs of those that use them. Those who specifically use opioids to 
self-medicate have unique characteristics and physiological needs. Opioid users are described as 
angry, aggressive, and having a critical self-view (Blatt, Rounsaville, Eyre, & Wilber, 1984). 
When there is no proper affective outlet, the mismanaged anger of children from poor attachment 
relationships can develop into rage and aggression. Heroin is a substance that soothes the 
experiences of anger, and prevents impulsive demonstrations of anger (Blatt et al., 1984; 
Khantzian, 1985). Cynicism, defined as a high level of anger towards others, predicted heroin use 
in a study conducted by Suh, Ruffins, Robins, Albanese, & Khantzian (2008). Although opioids 
are often taken for their somatic pain reducing qualities (Dodgen & Shea, 2000), they also regulate 
the painful affect expressed through rage and aggression (Khantzian, 1985; Khantzian, Mack, & 
Schatzberg, 1974). This deeply rooted painful affect stemming from childhood experiences is 
assuaged by opioids that provide a feeling of euphoria, as they produce a sensation similar to the 
symbiotic attachment with the mother attachment figure experienced during infancy (Cassidy, 
1999; Julien, 2000; Schindler et al., 2009; Stanton, Todd, Heard, Kirschner, Kleiman, Mowatt, ... 
& Van Deusen, 1978).  Heroin blunts the anxiety created by the unresolved desire to be 
independent from their attachment figures and family. The desire to be close but distant is 
enhanced by opioids’ sensation of cognitive inhibition and isolation, where users can be mentally 
and emotionally distant but still be physically present with their families. Opioids are seen as being 
attractive to users because of the ability to activate and deactivate emotions, and to resolve the 
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dissonance between feelings of closeness seeking and distancing from attachment figures 
(Schindler, Thomasius, Petersen, & Sack, 2009).  
There is convincing evidence for the self-medicating hypothesis in opioid using 
populations; as the strongest relationship between a specific attachment style and a substance is 
between fearful avoidant attachment and opioids (Finzi-Dottan, Cohen, Iwaniec, Sapir, & 
Weizman, 2003; Schindler, Thomasius, Sack, Gemeinhardt, Kustner, & Eckert, 2005; Schindler, 
Thomasius, & Petersen Sack, 2009). As noted earlier, fearful avoidance attachment is the desire 
for relationships but the behavior of distancing in fear of social rejection (Bartholomew & 
Horowitz, 1991). These individuals have negative views of themselves and others which is the 
consequence of inadequate relationships with attachment figures during childhood, and is 
characteristic of the upbringing of many addicts (Brooks, 1997). Research shows that opioid users 
utilize the substance as an emotional substitute for social attachment, as it assists with their desire 
to withdraw from others (Insel, 2003; Zimmer-Hofler & Kooyman, 1996).   
Opioid users have been described as a troubling group who have the lowest levels of 
psychosocial functioning and the highest level of daily life disruptions, compared to ecstasy and 
cannabis using groups (Schindler, Thomasius, & Petersen Sack, 2009). Markou, Kosten, and Koob 
(1998) compared non-clinical samples as well as substance users of opioids, alcohol, and cocaine. 
They found that major depressive disorder had a much higher prevalence in opioid users compared 
to the aforementioned groups. Their review provided support that opioids were the most powerful 
and preferred substance for those who lacked functional coping strategies and had attachment 
related distress. In regards to the debate of whether negative affect is subsequent of drug use or if 
drug use is subsequent to the negative affect, recommended treatment of the comorbid conditions 
aimed to illuminate this.  Thorberg and Lyvers (2005) provided evidence that even after abstinence 
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from drug use patients still had difficulties with regulating their emotions. Suh, Ruffins, Robins, 
Albanese, and Khantzian (2008) posited that abstinence can be maintained once the patient’s 
aggression is managed. These researchers are eluding to negative affect being the primary issue, 
and the substance abuse serving as a consequence of this affect. Based on Bandura’s self-efficacy 
theory (Bandura, 1977), the development of substance use disorder stems from the belief that there 
are pain reducing benefits of the drug use, as well as the disbelief that one would be able to regulate 
the pain related affect without the use of drugs (Hersen, Rurner, & Beidel, 2007).  
Neurobiology of Affect and Substance Use. According to Young, Lawford, Nutting, and 
Noble (2004) drug addiction is not only the association of environmental cues and substances, but 
it is also the ability to continually activate the dopamine system. There have been numerous studies 
that have sought to connect addiction of substances and negative affect to the dopamine system 
(Shaffer, LaPlante, LaBrie, Kidman, Donato, & Stanton, 2004). Markou and colleagues (1998) 
established some similarities between depression and drug use. They identified that both clinical 
presentations bring about neurobiological changes in the human reward and motivational 
processes, both express similar neurobiological abnormalities, that antidepressants improve both 
mood and substance abuse, and that there is a high comorbidity between the two disorders which 
both have theoretical grounding in familial aggregation etiology. In the specific case of opioids, 
decreases in the neurotransmission of dopamine, and increases in norepinephrine and the 
corticotropin-releasing factors, are all altered functions of neurotransmitters in the experience of 
depression and opioid withdrawal. Blockage of the opiate receptors and the dopamine receptors in 
the nucleus accumbens both produce signs of opioid withdrawal. The nucleus accumbens is the 
part of the limbic system that involves rewards, pleasure, and addiction (Shaffer et al., 2004). The 
limbic system manages motivational and affective processes (Markou, Kosten, & Koob, 1998), 
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and has the greatest amount of opiate receptors in the brain (Schindler, Thomasius, & Petersen 
Sack, 2009). 
A review by Schindler and colleagues (2009), identified connections between the opiate 
system and attachment in various animal subjects. When rats separated from their mothers were 
given opioids their expressions of distress decreased; but then increased when they were 
administered opioid antagonists (Panksepp, 1998). An escalation in the motivation for care and 
closeness was apparent in young and adult primates when they were given opiate receptor 
antagonists (Martel, Nevison, Simpson, & Keverne, 1995; Graves, Wallen, & Maestripieri, 2002; 
Keverne, Martensz, & Tuite, 1989). Conclusively, Schindler et al.’s (2009) review found that 
opioid use relieves attachment related distress and decreases the need for social engagement, but 
lack of opiate agonists showed greater need for social attention and care. 
The conditioning of the opioid system is also connected to attachment. Positive interactions 
with an attachment figure produces a calming effect by releasing endorphins during these 
interactions. Endorphins are neurotransmitters that cause a feeling of euphoria in the brain. 
Repeated experiences with the attachment figure, create a conditioning of the opioid system to 
release endorphins whenever there is a stimulus of the attachment figure or when the figure is 
present. When the early interactions with the attachment figure are less pleasant, there are less 
endorphins released and less conditioning that takes place in the opioid system. Consequentially, 
pleasure from social interactions are not as easily derived because it is more difficult for the opioid 
system to respond during interactions.  An increase of opioids in the system help rectify this 
imbalance, and become more attractive to those who have insecure attachment styles (Insel, 2003; 
MacLean, 1990; Zimmer-Hofler & Kooyman, 1996).  
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Co-morbidities between negative affects (such as depression) and substance abuse are 
highly substantiated in the literature (Shaffer et al., 2004). It is vital to recognize that these clinical 
presentations have striking neurobiological mechanism similarities. Thus, it is intuitive that where 
there is a chemical deficit in affect, that the individual would be attracted to using opioids as a 
means to balance this deficit and better regulate their emotions, especially in regards to experiences 
with their attachment figures.   
Methadone Using Populations. As previously noted, opioid users experience great 
dysfunction in their daily lives in regards to relationships, work, and school (Schindler et al., 2009). 
Many users will seek treatment to enhance their quality of life (Torrens, Domingo-Salvany, 
Alonso, Castillo, & San, 1999). Being that they want to prevent withdrawal symptoms but still 
manage their physical dependence on opioids, users may enroll in a medically assisted facility 
such as a methadone clinic. The frequent, in most cases daily, methadone dosing provides a sense 
of structure in the lives of those whose lives may have lacked structure since their childhood. These 
users create a community amongst themselves, which create a sense of independence through the 
social connections outside of their families (Stanton et al., 1978). Independence is a long time goal 
of users, especially those who did not properly resolve their individuation phase in toddlerhood 
(Brooks & Rice, 1997). Opioid users are said to be attracted to methadone treatment in order to 
transfer their addiction from their opioid of choice to the methadone medication. To these 
criticisms, it is important to acknowledge that the primary goal of these facilities is to reduce 
dependency on any opioids, methadone included (Prus, 2013). Furthermore, many medically 
assisted treatment facilities provide psychosocial counseling to help their patients manage their 
affect based difficulties (Bell, Burrell, Indig, & Gilmore, 2006). This comprehensive treatment is 
necessary because if patients were previously regulating their emotions by using opioids, they 
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could return to using if they were not given the coping skills needed to handle the stress of 
experiencing affect without opioid regulation (Brewer, Catalano, Haggerty, Gainey, & Fleming, 
1998).  Understanding how ruptures in early development can lead an individual to addiction and 
later methadone treatment, provides the foundation necessary to connect the variables of interest 
of this study and how they influence substance abuse treatment outcomes.   
Purpose of the Study 
Bowlby (1973), Ainsworth (1989), Bartholomew and Horowitz (1991) established that 
damaged attachments create interpersonal styles that continue in relationships throughout life. The 
literature shows that addicts may have developed insecure attachments likely due to neglect, 
trauma, or familial substance abuse during their childhood (Windom & Hiller-Sturmhofel, 2001). 
Patients who are in substance abuse recovery may have family members who respond to their 
tangible needs, but are still lacking in the emotional support and care that is needed for 
rehabilitation (Tracy et al., 2010). Family systems literature posits that families operate under a 
homeostasis, and that this homeostasis could include addiction (Day, 2008; Jackson & Weakland, 
1961; Nichols & Schwartz, 2004). Given this conceptualization family members unknowingly rely 
on the identified patient remaining in addiction, as their recovery would cause disruptions to the 
family narrative. Roles that family members have been operating in would need to change, and the 
family system may not be able to or willing to undergo such reconstruction.  
Thus addicts in recovery with the support of a poorly functioning family and damaged 
attachments, may be receiving help from a system that is not fully committed to their improvement 
(Anderson, Goolishian, & Windermand, 1986; Papero, 1995). These patients may be re-exposing 
themselves to the rejection and discouragement that they experienced during their development; 
whether this is via biological relatives or replicative patterns in a new relationship (Bartholomew 
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& Horowitz, 1991). They may still be receiving messages that they are “no good” and incapable 
(Ackerman, 1983; Brooks & Rice, 1997; Brown, 1985). For this reason this study sought to assess 
if these patients had a decreased ability to resist substance use, a perceived lowered satisfaction in 
life or lower self-efficacy in regards to meeting the goals of their substance abuse treatment. 
It is pivotal to deepen the understanding of the role played by family members, as well as 
the level of functioning of the family system in order to inform treatment approaches. Mental 
health providers could strengthen clinical work with substance abuse patients by assessing the 
specificity of a patient’s social support beyond reported concrete assistance. Such information 
could help identify the social network needs of the patient or highlight interventions that otherwise 
may not have been considered.  
Hypotheses 
A review of the literature identified several inquiries to be addressed through this research. There 
is evidence that tangible support and positive relationships from a support network can be 
predictive of positive substance abuse treatment outcomes (Beattie et al.,1993; Broome, Knight, 
Knight, Hiller, & Simpson, 1997; Brown, O’Grady, Battjes, & Katz, 2004; Costantini, Wermuth, 
Sorensen, & Lyons, 1992; Gruber & Fleetwood, 2004; Havassy, Wasserman, & Hall, 1991; 
Huselid, Self, & Gutierres, 1991; Moore & Finkelstein, 2001; O’Farrell & Feehan, 1999; 
Westreich, Heitner, Cooper, Galanter, & Gued, 1997). However not all types of support, including 
tangible support, served as beneficial for one’s recovery (Tracy et al., 2010). This was especially 
salient if there were negative aspects of the relationship between the identified patient and their 
social support (Tracy et al., 2010). Assessing patient’s drug use obtained by biological measures, 
in combination with secondary outcomes such as self-efficacy and quality of life is the 
recommended way to measure substance abuse treatment efficacy (Tiffany et al., 2012). In interest 
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of self-efficacy, close relationships and greater emotional support have been found to improve self-
efficacy in substance use interventions. In consideration of quality of life, social support enhances 
one’s ability to recover and enriches their satisfaction in life to sustain the progress made after 
undergoing treatment (Dobkin, De Civita, Paraherakis, & Gill, 2002; Garmendia, Alvarado, 
Montenegro, & Pino, 2008).  
Given these cumulative findings, my first research aim sought to establish if differences in 
tangible support affected treatment outcomes. Specifically, I hypothesized that tangible support 
would have a positive relationship with both self-efficacy (hypothesis 1) and quality of life 
(hypothesis 2), and a negative relationship with drug use (hypothesis 3). My second research aim 
was to determine if the level of family functioning affected treatment outcomes. I distinctly 
theorized that family functioning would have a positive relationship with both self-efficacy 
(hypothesis 4) and quality of life (hypothesis 5), and a negative relationship with drug use 
(hypothesis 6).  See figure 1 for an illustration of hypotheses one through six.  
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                  Predictors          Outcomes 
 
 
 
 
 
 
 
 
Figure 1. Hypotheses one through six demonstrating the relationship between tangible support and 
family functioning on treatment outcomes: self-efficacy, quality of life, and drug use. 
 
 My final hypotheses stemmed from literature that established a relationship between 
familial support and treatment outcomes (Min, Tracy, & Park, 2014). More specifically, that 
family functioning determines the family’s ability to be supportive during times of substance use 
recovery (Ellis et al., 2004; O’Farrell, et al., 1998; Tracy et al., 2010). For this reason, my third 
aim was to determine if there would be a positive relationship between tangible support and 
treatment outcomes, but that this relationship would vary based on level of family functioning. 
Within this aim, it was hypothesized that family functioning would moderate the relationship 
between tangible support and self-efficacy (hypothesis 7), quality of life (hypothesis 8), and drug 
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Moderator 
use (hypothesis 9) as treatment outcomes. At higher levels of family functioning, tangible support 
would have a positive relationship with self-efficacy and quality of life, and a negative relationship 
with drug use. However at lower levels of family functioning, tangible support would reduce or 
even eliminate the relationships with self-efficacy and quality of life, and increase the relationship 
with drug use. See figure 2 for illustration of hypotheses seven through nine. Identifying family 
functioning as an underlying construct of support received from one’s family, could help explain 
mixed findings in the literature in regards to how social support affects the recovery of those in 
substance abuse treatment (De Vogli, Chandola, & Marmot, 2007; Tracy et al., 2010; Trulsson & 
Hedin, 2004), specifically in regards to the family system. 
                  Predictor          Outcomes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Hypotheses seven through nine demonstrating family functioning’s moderating 
relationship between tangible support and treatment outcomes: self-efficacy, quality of life, drug 
use. 
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Methods 
Participants 
Participants were patients at a medically assisted treatment clinic in downtown Richmond, 
Virginia. Inclusion criteria were: be at least 18 years of age and currently enrolled in the clinic. 
The exclusion criterion was: enrollment in the program for three months or less (to allow time for 
treatment response). Data was collected from 125 participants, but 110 participants were included 
due to the study exclusion criteria. The facility’s enrollment population was approximately 63.63% 
females and 36.6% males. Around 74% of the population identified as African American, and 24% 
identified as Caucasian. The average age of the population was 45 years old. Approximately 91.6% 
of their patients were being medically treated for opioid abuse with Methadone, and 6.29% were 
being treated with Suboxone. Participants were recruited via a flyer advertisement and through 
word-of-mouth. The study advertisement was posted in the pharmacy department of the clinic, 
which is the patient entrance of the facility. The flyer included information about the study as well 
as inclusion criteria and instructed potential participants to contact the primary researcher through 
the agency’s primary phone line. Referral strategies utilized facility patients and a facility liaison 
to refer interested participants to the primary researcher.  
Measures 
Family Functioning. The Family Assessment Device is a scale that was created using the 
McMaster Model of Family Functioning (MMFF) (Epstein, Baldwin, & Bishop, 1983). This 
measurement contains seven different subscales, however, the General Functioning Subscale 
(FAD-GS) was used for the purposes of this study. There was robust support in the literature that 
demonstrated that this 12-item subscale adequately captures family functioning, by assessing 
  
 
47 
 
problem solving, communication, family roles, affective responsiveness, affective involvement, 
and behavioral control (Ridenour, Daley, & Reich, 1999). The survey asked participants to answer 
questions about their family, using response options that included “Strongly Agree” “Agree” 
“Disagree” and “Strongly Disagree.” Examples from this measure included, “We avoid discussing 
our fears and concerns,” and “We are able to make decisions about how to solve problems.” The 
alpha coefficient for the general functioning subscale is .91. The subscale’s averages were obtained 
to calculate family functioning scores. The higher the score, the greater the indication of family 
dysfunction. Any mean subscale scores 1.68 or above are considered dysfunctional and stressed 
families. Subscale scores below 1.49 are considered well-functioning and non-stressed family 
units. 
Tangible Support. The Inventory of Socially Supportive Behaviors (ISSB; Barrera, 
Sandler & Ramsay, 1981) assessed tangible and emotional aspects of perceived support. This 
measure asked participants to consider the past four weeks and to respond with the frequency of 
social support behaviors received by family members. Example items included, “Looked after a 
family member when you were away,” “Provided you with a place to stay,” and “Loaned you over 
$25.”  The item responses included “Not at all,” “Once or twice,” “About once a week,” “Several 
times a week,” and “About every day.” The tangible support scale was used in the data analysis. 
The alpha coefficient for this measure is .926. Scores from the responses were averaged to obtain 
a scale score to be included in the data analysis. Larger scores signified a greater amount of tangible 
support received from family members.  
Self-Efficacy. The patient’s self-efficacy was assessed using the shortened version of the 
Drug Taking Confidence Questionnaire (DTCQ-8; Sklar & Turner, 1999). This measure provided 
a few brief scenarios, and queried participants about their level of confidence that they could resist 
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using their drug of choice during a relapse crisis situation. This confidence percentage scale, 
ranged from 0 (not at all confident that they could resist) to 100 (very confident that they could 
resist) in increments of 20. Examples of questions included, “I would be able to resist the urge to 
use heavily: If other people treated me unfairly or interfered with my plans;” or “I would be able 
to resist the urge to use heavily: If I had trouble sleeping.” Annis and Martin (1985), the creators 
of the original Drug Taking Confidence Questionnaire (DTCQ), sought to consider relapse crisis 
scenarios that feature unpleasant emotions, physical discomfort, pleasant emotions, testing 
personal control, urges and temptations to use, conflict with others, social pressures to use, and 
pleasant times with others. The questions on the DTCQ-8 account for 95% of the variance of the 
DTCQ total. The alpha coefficient for the DTCQ-8 is .89. The DTCQ has also been used in 
previous studies examining self-efficacy in an opioid recovery population (Reilly, Sees, Shopshire, 
Hall, Delucchi, & Tusel, 1995). The global self-efficacy score was obtained by calculating the 
mean of the eight responses. Higher scores on the DCTQ-8 meant that the participant had a higher 
degree of self-efficacy to not use opioids. 
Quality of Life. Perceptions of quality of life were assessed with the World Health 
Organization Quality of Life-BREF (WHOQOL-BREF) measure. This brief measure is a 26-item 
survey adapted from the original 100 question WHOQOL-100 assessment (WHOQoL Group, 
1998). The WHOQOL-BREF evaluates four domains: physical health, psychological wellness, 
social relationships, and environment. In addition to these domains, there are two specific 
questions that assess for overall quality of life and general health. Participant responses were rated 
on a 5-point Likert scale, where the responses varied by the nature of the item. Example items 
included, “How well are you able to get around,” “How satisfied are you with your capacity to 
work,” and “How often do you have negative feelings such as blue mood, despair, anxiety, 
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depression?” The alpha coefficient of the measure is 0.701 (Najafi, Sheikhvatan, Montazeri, & 
Sheikhfathollahi, 2009). The total rating score on the survey was indicative of the participant’s 
score on this measure. Essentially, the higher the total score the greater the perceived quality of 
life by the participant.  
Current Drug Use. The methadone facility conducts patient urine screens once a month, 
and they corroborate this information through the prescription drug monitoring program (PDMP). 
According to the expert panel assembled by NIDA to establish standardized outcomes of 
treatment, biological measures of drug use are a necessary way to capture evidence of any 
substance use in addiction populations (Bühringer, Kraplin, & Behrendt, 2012). The PDMP is 
utilized by medical providers to monitor prescription information in efforts to minimize illegal use 
of substances (Orr, 2015).  To have a fortifiable confirmation of patient’s drug use, it is considered 
best practice to utilize the PDMP to verify that substances detected in patients’ urine are all 
medically prescribed (Owen, Burton, Schade, & Passik, 2012). The participants’ urine screen 
results and PDMP information from the month prior to their involvement in the study were used 
to establish patient drug use in the past month. If urine screens revealed any positive results of 
opioid usage in the past month, outside of medical dosage and prescriptions, the participant was 
identified as engaging in opioid use in the past month. 
Demographic Questions.  Participants were queried about general demographic 
information (i.e. age, race, employment status, marital status, etc.). There were a few demographic 
questions that were of interest to the study that were included. In a self-efficacy study conducted 
by Dolan, Martin, and Rohsenow in 2008, specific drug related inquiries were presented with 
demographic questions to discriminate participants’ risk of relapse. Subsequently, the present 
study included questions such as “Length of time in treatment,” “Drug of Choice,” “Age of initial 
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use,” and “Number of enrollments in substance abuse treatment.” Substance abuse history for the 
family members of the participant were included through brief inquiries. These persons were 
identified solely by their relationship to the participant and by no other identifiers. These inquiries 
included, “Did your______________ (mother/father/other family member) use during your 
childhood? If so, which substances?”  
Procedure 
Surveys were made available to participants by the primary researcher, upon their request, 
during facility visits when they were scheduled to receive services (i.e. dosing, counseling, or other 
medical services). The purpose of the study was explained to interested participants one at a time 
by the primary researcher in a private room at the facility. After reading the consent document, 
interested participants agreed to partake by signing their names via the consent form. During this 
time the primary researcher assessed for participant literacy. Consent forms also asked permission 
to access their drug use information via the facility databases. Then participants received an 
assessment packet labeled with a participant number. The primary researcher retained the names 
of participants and assessment packet numbers in a confidential database.  
After providing written consent, they began the assessment by answering demographic and 
substance abuse history questions. The participants then completed the DTCQ-8, the ISSB, the 
FAD-GS, and the WHOQOL-BREF questionnaires. Upon completion of the measures, study 
participants’ consents forms and survey responses were collected by the researcher and placed into 
the designated “survey” and “consent form” collection boxes. The purpose of keeping these 
documents separate was to maintain participant confidentiality. The patients were compensated 
with $10 in cash immediately after completing the study. After the participant completed the study, 
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the primary researcher subsequently reviewed the drug use information of each participant for the 
past month using the facility databases. These data were de-identified and kept with the 
participant’s assessment responses for the data analysis. Only the primary researcher had access 
to the master list of the patient’s participation numbers, and this document was electronically 
stored and password protected.   
 
Results 
Data Analytic Strategy  
Cohen’s statistical power guidelines (Cohen, 1988; Cohen, 1992) were used to determine 
the sample size needed to achieve a medium effect size.  In order to produce a medium effect size 
(r = .3), Cohen’s statistical power guidelines advised that I obtain at least 85 participants to include 
in the analysis. Given the possibility that missing participant responses could reduce the power of 
the data analysis, I collected more than the Cohen guidelines advised, by collecting 125 
participants (Tabachnick & Fidell, 2007). The motivation of my sample amount also ensured that 
I met the 10 cases per variable rule (Concato, Peduzzi, Holford, Feinstein, 1995; Peduzzi, Concato, 
Feinstein, & Holford, 1995).  
SPSS Version 22 was used for the data analyses in my study. All of the collected data was 
assessed for missing values and inconsistent data values that could have affected my analyses. No 
scales were missing 20% of the responses to qualify for removal from the analysis. However where 
missing responses existed, a scale score was created in order for the participant’s responses to be 
included (Tabachnick & Fidell, 2007). Before conducting my analyses, the study data was assessed 
for normality, linearity, univariate and multivariate outliers, missing data, homogeneity of 
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variance, and multicollinearity.  Prior to assessing the fit of my models, the data underwent a 
descriptive analysis including a calculation of means, standard deviations, and an assessment of 
the correlation between the study measures. See tables 1 and 2. Scale computations were done for 
self-efficacy, social support, family functioning, and quality of life. Also, the continuous predictor 
variables (tangible support and family functioning) were centered in preparation for the 
moderation analysis to reduce the potential for multicollinearity. There was an interaction term 
that was created between tangible support and family functioning; also for the moderation 
analyses. 
Table 1. Mean, Standard Deviation, Range, Skewness and Kurtosis  
 Mean SD Minimum Maximum Skewness Kurtosis 
DTCQ 77.23 22.32 15.00 100.00 -.805 -.413 
ISSB 2.20 1.08 1.00 5.00 .816 .020 
FADGS 2.13 .57 1.00 3.75 .201 -.170 
WHOQOLB 86.16 16.66 40.00 120.00 -.279 -.241 
 
Note: DTCQ = Drug Taking Confidence Questionnaire (self-efficacy); ISSB = The Inventory of 
Socially Supportive Behaviors (tangible support); FADGS = Family Assessment Device 
General Functioning Scale (family functioning); WHOQOLB = World Health Organization 
Quality of Life-BREF (quality of life); Minimum and Maximum values of participant responses 
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Table 2. Correlations among study measures  
Study Measures   1 2 3 4 5 
1. DTCQ --     
2. ISSB -.004 --    
3. FADGS -.269** -.245** --   
4. WHOQOLB .252** .122 -.300** --  
5. Opioid Drug Use -.239* .004 -.071 -.094 -- 
Note: *p < .05. **p < .01. 
Note: DTCQ = Drug Taking Confidence Questionnaire (self-efficacy); ISSB = The Inventory of 
Socially Supportive Behaviors (tangible support); FADGS = Family Assessment Device 
General Functioning Scale (family functioning); WHOQOLB = World Health Organization 
Quality of Life-BREF (quality of life) 
  
Descriptive Statistics 
Women were 68.2% of the sample; males were 30.9%, and 0.9% of the sample identified 
as transgender. In regard to age, 22.2% of the sample was between 20 to 35 years of age, 41.7% 
of the sample was between 30 to 45 years old, 34.3% of the sample was between 50 to 65 years 
old, 1.8% was 65 years of age and older, and two participants did not provide their age. 
Approximately 40% of the sample had some high school level education, another 42.7% reported 
having a high school degree or GED, 13.5.% had some college education, about 0.9% had a 
bachelor’s degree, 2.7% of the sample had a professional or graduate degree, and .9% of the sample 
did not report their education level.  
As far as the sample’s socioeconomic status (SES), 44.5% identified as lower SES, 50.0% 
identified as having middle SES, 1.8% identified as upper SES, and about 3.6% did not report their 
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socioeconomic status. Black participants comprised 82.7% of the sample, white participants made 
up 13.6%, and 3.6% identified as another race (i.e. mixed race or Hispanic). In consideration of 
participants’ relationship status, 49.1% identified a single and not in a relationship, 12.7% reported 
that they were in a relationship but not engaged or married, 16.4% reported that they were engaged, 
8.2% shared that they were married, 1.8% said that they were separated, 4.5% were divorced, and 
7.3% reported an “other” status (i.e. widow or widower). Participants’ parental status included 
having no children (8.2%), being the biological primary caretaker (56.4%), having biological 
children but not being the primary caretaker or having adult children (26.4%), having step children 
(2.7%), 5.5% identified being in an “other” category (i.e. primary guardian of grandchildren), and 
0.9% did not respond regarding their parental status.  
The majority of the sample preferred heroin (80%), 12.7% favored opiate pills, and 7.3% 
said that their drug of choice was both heroin and pills. When queried about the age of their first 
opioid use, 38.5% of the sample said that they began using opioids during their teenage years or 
younger, 44.5% shared that they began using opiates between 20 to 29 years old, 9.1% of the 
participants disclosed that they began using between 30 to 39 years of age, 5.5% began using 
opioids during the ages of 40 to 49, 1.8% first engaged in opiate use in their 50’s, and 0.9% chose 
not to report their age of first use.  
The participants in the study sample varied as far as their length of treatment at the facility. 
About 22.7% had been enrolled for more than 3 months but less than a year 1 year, 35.5% had 
been enrolled for 2-3 years, 14.5% had been enrolled for 3-5 years, 13.6% had been enrolled 
between 5-10 years, and about 11.8% had been enrolled for 10 or more years. Approximately 
26.4% of the patients’ reported that this was their first time in a substance abuse treatment program. 
About 18.2% of the sample were experiencing their second substance abuse treatment enrollment, 
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24.5% were in their third enrollment, 12.7% were in their fourth enrollment, 8.2% were in their 
fifth enrollment, and 4.5% have been in enrolled in a substance abuse treatment program six or 
more times.  
Participants’ current level of family communication included 53.6% who had daily 
communication, 22.7% are in communication with their family a few times a week, 11.8% 
communicate with their family a few times a month, 5.5% are in communication with their family 
members a few times a year, 5.5% were also in communication with their families once a year or 
less, and .9% did not respond to the inquiry.  
Upon review of the participant’s urine screens and prescription drug monitoring program 
information, it was found that 79.1% of the sample did not use opioids in the past month and 20.9% 
used opioids in the past month. When participants’ use of non-opioid drugs was assessed, it was 
revealed that 69.1% of the sample did not use any non-opioid drugs in the past month, and 30.9% 
of the sample were found to have used non-opioid drugs in the past month. In regard to the patients 
who were positive for opioid and/or non-opioids drugs, 77.55% of them did not have a prescription 
on file for the substance found in the urine, 16.32% did have prescriptions, and 6.12% of them had 
prescriptions for some of the substances found in their urine but not all. More descriptive statistics 
can be found detailed in Table 3.  
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Table 3. Descriptive Statistics of Participant Sample 
Descriptive Variables  Participant Number (N=110) 
Gender  
Female 75 
Male 34 
Transgender 1 
Age  
20-35 24 
36-50 45 
51-65 37 
65 and over 2 
Education  
Some high school 43 
High school degree or GED 47 
Some College 11 
Bachelors Degree 1 
Graduate School or Professional Degree 3 
Socioeconomic Status  
Lower SES 49 
Middle SES 55 
Upper SES 2 
Race  
Black 91 
White 15 
Other 4 
Relationship Status  
Single 54 
Dating 14 
Engaged 18 
Married 9 
Separated 2 
Divorced 5 
Other                                     8  
Parental Status  
No children 9 
Biological Primary caretaker 62 
Biological Not Primary Caretaker 29 
Step Children Primary Caretaker 3 
Other 6 
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Opioid of Choice  
Heroin 88 
Pills 14 
Both 8 
Age that Participant Started Use  
10-19 42 
20-29 49 
30-39 10 
40-49 6 
50-59 2 
Length of time in treatment at current facility  
Over 3 months to 1 year 25 
2-3 years 39 
3-5 years 16 
5-10 years 15 
10 or more years 13 
Enrollments in Substance Abuse Treatments  
One 29 
Two 20 
Three 27 
Four 14 
Five 9 
Six or more  7 
Level of Family Communication  
Daily 59 
A few times a week 25 
A few times a month 13 
A few times a year 6 
Once a year or less 6 
Opioid Use  
No Opioid Use in the past month 87 
Opioid Use in the past month 23 
Non-Opioid Drug Use  
No Non-Opioid Use in the past month 76 
Non-Opioid Use in the past month 34 
Prescription Status (n=49)  
No prescription on file 38 
Prescription on file 98 
Prescription on file for some but not all drugs in 
urine 
3 
  
 
58 
 
Assumptions  
Multiple Linear Regression Assumptions. The first assumption was that the predictor 
variables were quantitative or categorical, and that the outcome variable is continuous. The 
variables included in my linear regression analyses met this assumption. It was also established 
that the outcome variables were independent of one another. None of the predictors have variances 
of 0, and none were related to external variables. After assessing for correlations between the 
variables, it was determined that there was no multicollinearity between any of the predictor and 
outcome variables. Additionally, the tolerance was <1 and the VIF was below 10 for each variable, 
thus meeting the assumptions of no multicollinearity among the predictor variables. 
Univariate outliers were assessed by calculating z-scores of the variables, and evaluating 
if there were any responses that were two standard deviations away from the mean. The minimum 
and maximum values showed that none of the variables exceeded this critical value, thus meeting 
this assumption (Tabachnick & Fidell, 2007). Mahalanobis distance was examined for each 
variable and then compared with the critical value (Tabachnick & Fidell, 2007). Consequential of 
this, it was concluded that there were no multivariate outliers. Through assessment of the Durbin 
Watson test, the variables were found to have independent errors as the calculated values were >1 
but < 3 and close to 2, meaning that the residuals were uncorrelated. There was homoscedasticity 
among the predictor variables, and the mean values of the outcome variable were linear.  
Binary Logistic Regression Assumptions. Dichotomy of the outcome variable was 
determined, and the dependent variable was coded to reflect that (1) indicated the probability that 
the expected event occurred. After meeting those assumptions, it was established that the analyses 
would include at least 10 cases per independent variable. The linearity of the logit and 
multicollinearity assumptions of the binary logistic regression were also assessed prior to the 
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analysis. Interaction terms were created between the predictor variables and the log of themselves, 
and assessed for significance. Upon examination, it was determined that each of the predictor 
variables met this assumption. Additionally, each case derived from a onetime measured response 
from an individual participant. Multicollinearity among the predictor variables was ensured by 
assessing the tolerance, VIF, and eigenvalues. For each predictor the tolerance was <1, the VIF 
was below 10, and no two predictors had high values of variance proportions in the same 
dimension of eigenvalues. It was concluded that there was no multicollinearity among the 
variables. A stepwise method was used to ensure the model fit with meaningful variables. Upon 
confirming these criteria, it was determined that the data was appropriate for the binary logistic 
regression analysis. Prior to beginning the analyses, I also assessed for any possible confounding 
variables of the model.  
Tangible Support and Family Functioning Effects on Self-Efficacy 
Hypothesis one and two theorized that tangible support would have a relationship with self-
efficacy. To address these hypotheses, a multiple linear regression analysis was conducted. 
Covariates were assessed to see if any needed to be added to the model to control for their influence 
on the outcome variable. This included age, gender, SES, relationship status, length of time in 
treatment, and length of addiction. Gender was the only variable found to have a significant 
correlation with the outcome variable, thus this variable was included in the analysis.  The initial 
model featuring only the controlled variable was significant, F (1, 106) = 12.185, p = .001, R2 = 
.172. Gender was a significant predictor of self-efficacy as a treatment outcome, β = -.321, t (106) 
= -3.491, p = .001. Results of the linear regression analysis that included tangible support and 
family functioning showed that these variables significantly improved the prediction ∆R2 = .172, 
∆F (2, 104) = 4.307, p = .016. This finding demonstrates tangible support and family functioning 
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and gender, as a set, can predict a patient’s self-efficacy. The model was significant, F (2, 104) = 
7.186, p < .001, R2 = .172, accounting for 17.2% of the variance. Although, tangible support did 
not significantly predict self-efficacy, β = .005, t (107) = -.052, p = .959, family functioning was 
a significant predictor of self-efficacy, β = -.261, t (107) = -2.794, p = .006. Hypothesis one was 
not supported as tangible support did not have a significant relationship with self-efficacy. 
Hypothesis two was supported as family functioning did have a significant relationship with self-
efficacy. These results are reported in Table 4.  
Tangible Support and Family Functioning Effects on Quality Of Life 
Hypotheses four and five posited that family functioning would have a relationship with 
both self-efficacy and quality of life. A multiple linear regression analysis was used to assess these 
hypotheses. Covariates were examined by a correlational analysis to assess for any possible 
influence on the outcome variable. This included age, gender, education, socioeconomic status, 
race, relationship status, length of time in treatment, and length of addiction. Socioeconomic status 
was significantly correlated with quality of life, thus this variable was included in the model. The 
initial model featuring only the controlled variable was significant, F (1, 104) = 16.965, p < .001, 
R2 = .140. Socioeconomic status was a significant predictor, β = .374, t (104) = 4.119, p < .001. 
The addition of tangible support and family functioning slightly improved the model, ∆R2 = .063, 
∆F (2, 102) = 4.011, p = .021. The results of the full model featuring the predictor variables of 
interest was significant, F (3, 102) = 8.656, p < .001, R2 = .203, accounting for 20.3% of the model 
variance. This indicates that tangible support, family functioning, and socioeconomic status, as a 
set, can predict a patient’s perception of their quality of life. Tangible support was not able to 
significantly predict quality of life, β = .002, t (102) = .026, p = .979. Family functioning, on the 
other hand, was found to be a significant predictor of quality of life, β = -.252, t (102) = -2.752, p 
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= .007. In the final model, socioeconomic status maintained its significance as a variable, β = .339, 
t (102) = 3.759, p < .001. Hypothesis four was not supported as tangible support did not have a 
significant relationship with quality of life. Hypothesis five was supported as family functioning 
did have a significant relationship with quality of life. These results are reported in Table 4. 
Table 4. Multiple Linear Regression Analyses 
Outcome and Predictor 
Variables 
 B SE B Β t R2∆ 
  Self-Efficacy F (3, 104) = 7.186, p < .000, R
2 
= .172     
Step 1     .103 
Gender -14.223** 4.075 -.321 -3.491  
Step 2     .172 
Gender -13.841** 3.965 -.312 -3.491  
Tangible Support .105 2.025 .005 -.052  
Family Functioning  -9.933* 3.556 -.261 -2.794  
Quality of Life F (3, 102) = 8.656, p < .001, R
2 
= .203     
Step 1     .140 
Socioeconomic Status 11.643** 2.827 .374 4.119  
Step 2     .063 
Socioeconomic Status 10.539** 2.804 .339 3.759  
Tangible Support .037 1.419 .002 -.026  
Family Functioning  -7.403* 2.690 -.252 -2.752  
Note: *p < .05. **p < .001.   
 
Tangible Support and Family Functioning Effects on Opioid Use 
Hypotheses three and six aimed to determine if tangible support and family functioning 
influence patients’ drug use. A logistic regression was used to examine these hypotheses.  Prior to 
running the model, age, gender, parental status, addiction length, treatment length, and non-opioid 
drug use were assessed as potential confounding variables. Non-opioid drug use was significantly 
correlated with opioid drug use as the outcome variable, thus it was included in subsequent 
analyses. Due to its categorical nature, the analysis ran non-opioid drug use with both internal 
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categories: no non-opioid drug use in the past month (category 0) and non-opioid drug use in the 
past month (category 1). The analysis only featuring non-opioid drug use as a Step 1 predictor, 
was significant, χ 2 (1, N = 110) = 23.690, p < .001. No non-opioid drug use as a predictor (category 
1) was significant, 2(1) = 20.213, p < .001; OR = .086 (CI = .029 – .250). In Step 2, a test of the 
full model against the constant-only model was significant, χ 2 (3, N = 110) = 24.410, p = .001. 
However, tangible support was not a significant predictor of opioid use, χ2 (1) = .321, p = .571; 
OR = .866 (CI = .547 – 1.423). Family functioning was also unable to significantly predict opioid 
use, χ2 (1) = .532, p = .466; OR = .695 (CI = .262 – 1.846). These results illustrated that hypotheses 
three and six were not supported by the study’s data. 
Subsequently, the model was able to differentiate between those who used opioids outside 
of their methadone dose and prescriptions, and those who did not use opioids outside of their 
methadone dose. This finding, however, could not be attributed to the influence of tangible support 
or one’s family functioning as predictor variables. The variable with the greatest significant impact 
on the model was participant’s use of non-opioid drugs, specifically those who did not use non-
opioid drugs in the past month, χ2 (1) = 20.206, p < .001; OR = .083 (CI = .028 – .246). The 
accurate classification of cases from the predictor was high for the prediction of those who did not 
use opioids outside of their medical prescriptions and facility dose (90.8%), and moderately low 
for those who did use opioids outside of their medical prescriptions and facility dose (47.8%). 
Overall, the model was able to reliably discern between individuals who used opioids in the past 
month from those who did not use opioids in the past month (81.8%). Data from the logistic 
regression analyses can be found in Table 6. 
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Family Functioning as a Moderator between Tangible Support and Self-Efficacy  
Hypotheses seven sought to understand if family functioning moderated the relationship 
between tangible support and self-efficacy. A step-wise hierarchical method was used to run a 
multiple linear regression to assess this hypothesis. The variables age, gender, socioeconomic 
status, relationship status, length of addiction, and length of time in treatment were assessed for a 
correlational relationship with self-efficacy as an outcome variable. None of the possible 
covariates were found to have a significant relationship with self-efficacy, thus none were added 
to the analysis to assess third variable influence. The predictor variable tangible support was 
centered and entered into the step-wise hierarchical multiple regression analysis. There was no 
significant improvement from the constant only model, ∆R2 = .000, ∆F (1, 108) = 0.002, p = .967. 
Findings from this step revealed that the model was not a significant predictor of self-efficacy, F 
(1, 108) = 0.002, p = .967, R2 = .000.  
The centered tangible support predictor was not found to be a significant predictor of self-
efficacy in this model, β = -.004, t (108) = -.041, p =.967. Family functioning was then centered 
and added to the model. This addition improved the model, ∆R2 = .076, ∆F (1, 107) = 8.834, p = 
.004; and this model was significant, F (2, 107) = 4.418, p = .014, R2 = .076. The centered family 
functioning predictor was found to be a significant predictor of self-efficacy in this model, β = -
.285, t (107) = -2.972, p =.004. For the final step, the interaction term between family functioning 
and tangible support was entered to test the full model against a constant-only model.  
Although it approached significance, the interaction term did not significantly improve the 
model, ∆R2 = .032, ∆F (1, 106) = 3.812, p =.054. However, the overall model was significant, F 
(3, 106) = 4.293, p = .007, R2 = .108, and accounted for 10.8% of the variance on the outcome 
variable. This indicates that as a set, the predictors (tangible support and family functioning) were 
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reliably able to discern participants’ self-efficacy in treatment. When the interaction term of family 
functioning and tangible support was assessed, it was not shown to be a predictor of self-efficacy, 
β = .181, t (106) = 1.953, p =.054. Thus, one’s family functioning considered with the tangible 
support received from their family, does not serve as a predictor of their self-efficacy in treatment.  
Hypotheses seven was not supported. These results are reported in table 5. 
Family Functioning as a Moderator between Tangible Support and Quality Of Life  
A step-wise hierarchical method was used to run a multiple linear regression to assess 
hypothesis eight. This hypothesis sought to understand if family functioning moderated the 
relationship between tangible support and quality of life. Prior to running the analysis, the 
following variables were examined for possible inclusion in the model: age, gender, 
socioeconomic status, education, race, relationship status, length of addiction, and length of time 
in treatment. Socioeconomic status was correlated with the outcome variable, and thus included in 
the model to be examined as a potential covariate. A test of the covariate against a constant-only 
model showed a significant change, ∆R2 = .140, ∆F (1, 104) = 16.965, p < .001, and the model 
was significant, F (1, 104) = 16.965, p < .001, R2 = .140. Socioeconomic status was found to be a 
significant predictor of the outcome variable, β = .374, t (104) = 4.119, p <.001.  
The predictor variable tangible support was centered and entered into the step-wise 
hierarchical multiple regression analysis. Findings from this step revealed that the model was a 
significant predictor of quality of life, F (2, 103) = 8.645, p < .001, R2 = .144, although it did not 
significantly improve the model ∆R2 = .003, ∆F (1, 103) = .177, p = .518. The centered tangible 
support predictor was not found to be a significant predictor of quality of life in this model, β = -
.060, t (103) = -.648, p = .518. Family functioning was then centered and added to the model. The 
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model was significant, F (3, 102) = 8.656, p < .001, R2 = .203, and was found to be an improvement 
upon the previous step, ∆R2 = .059, ∆F (1, 102) = 7.575, p < 0.10. The centered family functioning 
predictor was found to be a significant predictor of quality of life in this model, β = -.252, t (102) 
= -2.752, p =.007. For the final step, the interaction term between family functioning and tangible 
support was entered to test the full model against a constant-only model. The model was 
significant, F (4, 101) = 6.767, p < .001, R2 = .212. This model accounted for 21.2% of the variance 
on the outcome variable, but was not an improvement from the previous step ∆R2 = .009, ∆F (1, 
101) = 1.175, p = .281. This indicates that as a set, the predictors were reliably able to discern 
participants’ perceptions of their quality of life.  
When the interaction term of family functioning and tangible support was assessed, this 
was not shown to be a predictor of quality of life, β = .097, t (101) = 1.084, p =.281. Thus, one’s 
family functioning along with the tangible support that they receive from their family does not 
serve as a predictor of their quality of life. Socioeconomic status was a predictor controlled for in 
the model, which seemed to have the greatest influence on the model’s significant value β = .337, 
t (101) = 3.734, p < .001. Hypothesis eight was not supported by the data. The results from this 
analysis can be found in table 5. 
 
Table 5. Moderations for Multiple Linear Regression  
Outcome and Predictor 
Variables 
B SE B Β t R2∆ 
Self-Efficacy F (3, 106) = 4.293, p = .007, R
2 
= .108  
Step1      .000 
Tangible Support_Cent -.082 1.986 -.004 -.041  
Step 2     .076 
   Tangible Support_Cent -1.361 1.979 -.066 -.688  
Family Functioning_Cent -11.200* 3.768 -.285 -2.972  
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Step 3     .032 
 Tangible Support_Cent -1.515 1.955 .073 .775  
Family Functioning_Cent -12.381* 3.769 -.315 -3.285  
Tangible Support_Cent x 
Family Functioning_Cent 
7.071 3.622 .181 -1.953  
      
 B SE B Β T R2∆ 
Quality of Life F (4, 101) = 6.767, p < .001, R
2 
= .212  
Step 1    <.001 
Socioeconomic Status 11.643** 2.827 .374 4.119  
Step 2     .518 
Socioeconomic Status 11.326** 2.877 .364 3.937  
Tangible Support_Cent -.924 1.426 .060 -.648  
Step 3     .007 
Socioeconomic Status 10.539** 2.804 .339 3.759  
Tangible Support_Cent -.037 1.419 -.002 -.026  
Family Functioning_Cent -7.403* 2.690 -.252 -2.752  
Step 4     .281 
Socioeconomic Status 10.463** 2.802 .337 3.734  
Tangible Support_Cent -.019 1.419 .001 .014  
Family Functioning_Cent -7.882* 2.724 -.269 -2.894  
Tangible Support_Cent  x 
Family Functioning_Cent 
2.822 2.604 .097 
1.084 
 
          Note: *p < .05. **p < .001.; Cent: Centered predictor variables 
 
 
Family Functioning as a Moderator between Tangible Support and Opioid Use  
Hypothesis nine theorized that family functioning would moderate the relationship 
between tangible support and opioid use. A step-wise hierarchical method was used to run a binary 
logistic regression to assess this hypothesis. The analysis controlled for non-opioid drug use. Due 
to its categorical nature, the analysis ran non-opioid drug use with both internal categories: no non-
opioid drug use in the past month (category 0) and non-opioid drug use in the past month (category 
1). A test of the covariate against a constant-only model was significant, χ 2 (1, N = 110) = 23.690, 
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p < .001.  Non-opioid drug usage was significant 2(1) = 20.213, p < .001; OR = .086 (CI = .029 
– .250); specifically the category no non-opioid drug use in the past month.  
The predictor variable tangible support was centered and entered into the step-wise 
hierarchical multiple regression model. Findings from this step revealed that the model was a 
significant predictor of opioid drug use, χ 2 (2, N = 110) = 23.870, p < .001. The centered tangible 
support predictor was not found to be a significant predictor of opioid use in this model, tangible 
support 2(1) = 0.178, p = .673; OR = 1.109 (CI = .686 – 1.792). Family functioning was then 
centered and added to the model, and the model was significant, χ 2 (3, N = 110) = 24.410, p < 
.001. However, the centered family functioning predictor was not found to be a significant 
predictor of opioid use in this model, family functioning 2(1) = .532, p = .466; OR = .695 (CI = 
.262 – 1.846). 
 For the final step, the interaction term between family functioning and tangible support 
was entered to test the full model against a constant-only model, and the model was significant, χ2 
(4, N = 110) = 25.685, p < .001. This indicates that as a set, the predictors reliably discerned 
between those who engaged in opioid use outside of their methadone done and medical 
prescriptions and those who did not. When the interaction term of family functioning and tangible 
support was assessed, this was not shown to be a predictor of opioid use, 2(1) = 1.273, p = .259; 
OR = 1.723 (CI = .670 – 4.433). Thus, one’s family functioning along with the tangible support 
that they receive from their family does not serve as a predictor of opioids use outside of their 
methadone dose and prescriptions. Subsequently, hypothesis nine was not supported.  
No non-opioid drug use was a predictor controlled for in the model, which seemed to have 
the greatest influence on the model’s significant value, 2(1) = 20.447, p < .001; OR = .080 (CI = 
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.027 – .239). The classification of cases was high for the predication of those who did not use 
opioids outside of their medical prescriptions and facility dose (89.7%), and moderate low for 
those who did use opioids outside of their medical prescriptions and facility dose (52.2%). Overall, 
the model was able to somewhat reliably discern between individuals who are used opioids in the 
past month from those who did not use opioids in the past month (81.8%). Data from the binary 
logistic regression analyses can be found on Table 6. 
Table 6. Binary Logistic Regression Analyses  
Outcome and Predictor Variables B SE Wald OR CI 
Opioid Drug Use  χ 2 (3, N = 124) = 0.200, p = .001 
Step 1  
Non-opioid Drug Use 
 
-2.457** 
 
.546 
 
                20.213 
 
.086 
 
.029 – .250 
Step 2 
Non-opioid Drug Use  
Tangible Support 
Family Functioning  
 
-2.486** 
-.143 
-.364 
 
.553 
.253 
.498 
 
                20.206 
.321 
.532 
 
.083 
.866 
.695 
 
.028 – .246 
.262 – 1.423 
.262 – 1.846 
      
Tangible Support x Family Functioning χ2 (1) = 0.020, p = .603 
Step 1:  
Non-opioid Drug Use  
 
-2.457** 
 
.546 
 
20.213 
 
<.001 
 
.029 – .250 
Step 2:  
Non-opioid Drug Use 
Tangible Support_Cent 
 
-2.482** 
.103 
 
.551 
.245 
 
20.259 
.178 
 
<.001 
1.109 
 
.062 – .380 
.686 – 1.792 
 
Step 3:  
Non-opioid Drug Use  
 
-2.486** 
 
.553 
 
20.206 
 
.083 
 
.028 – .246 
Tangible Support_Cent 
Family Functioning_Cent  
Step 4:  
.143 
-.364 
 
.253 
.498 
.321 
.532 
1.154 
.695 
.703 – 1.896 
.262 – 1.846 
Non-opioid Drug Use  -2.528** .559 20.447 .080 .027 – .239 
Tangible Support_Cent 
Family Functioning_Cent 
Tangible Support_Cent*Family 
Functioning_Cent 
.160 
-.395 
.544 
.263 
.496 
.482 
.370 
.633 
1.273 
1.174 
.674 
1.723 
.700 – 1.967 
.255 – 1.782 
.670 – 4.433 
Note: *p < .05. **p < .001. 
Note: SE: Standard Error; OR: Odds Ratio; CI: Confidence Interval; Cent: Centered predictor variables 
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Discussion 
The current study sought to understand how the support and functioning of one’s family 
influences recovery from opiate addiction. Findings established that tangible support had no 
relationship with patient self-efficacy, quality of life, or drug use as treatment outcomes. Family 
functioning was found to have a positive relationship with patient self-efficacy and perceptions of 
quality of life; however, there was no relationship with drug use as a treatment outcome. 
Furthermore, family functioning did not moderate the relationship between tangible support and 
treatment outcomes.  
Analyses were conducted to assess if there was a relationship between tangible support and 
treatment outcomes (Hypotheses 1, 2, 3). It was hypothesized that tangible support would have a 
positive relationship with treatment outcomes; however, none of these hypotheses were supported. 
The social support literature demonstrates that tangible support can be either helpful or harmful, 
depending on the relationship quality with the giver of the support (Tracy et al., 2010). Previous 
research substantiates that tangible support, even if helpful, does not influence the completion of 
substance abuse treatment (Tracy et al., 2010). The findings of the current research add to the 
literature that tangible support does not have an influence on treatment outcomes, notably 
abstinence self-efficacy, perceived quality of life, and drug use. Specifically assessing tangible 
support as a treatment outcome, if someone responded to the ISSB measure (Barrera, Sandler & 
Ramsay, 1981) that they received assistance such as childcare or borrowing money, this does not 
translate to patient confidence in their ability to not use drugs. Tangible support may increase 
treatment compliance or keep recovering addicts out of legal trouble. However, as far as the 
addict’s internal beliefs about what they are capable of, these beliefs are not strongly influenced 
by concrete assistance from those around them.  
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If someone in recovery receives tangible help, this support would likely be perceived as 
beneficial for the treatment progress. However, it is important to acknowledge that some forms of 
tangible support can be detrimental. This is particularly true if patients feel that they are stuck in a 
situation where they must rely on the assistance (i.e. food and shelter), but feel hindered by those 
providing the support (i.e. being in conflict-ridden relationships, exacerbating patient’s guilt, 
and/or using substances around patient) (Tracy et al., 2010). Thus receiving tangible support, in 
some cases, may not translate into a reason why a recovering addict would feel that they are 
experiencing an overall better quality of life.  
 Irrespective of the tangible support received, results of the current study suggest that this 
help does not influence actual drug use patterns while one is in recovery. Dependency and 
addiction have biological and psychological foundations, respectively (Dependency, 2012). It is 
comprehensible that these internal mechanisms may permeate deeper than what can be influenced 
by an external factor such as tangible support. Tangible support alone may not make a strong 
enough impact to influence someone in recovery to refrain from drug use. These findings imply 
that variables with greater psychological underpinnings should be examined for their influence on 
treatment outcomes.  
Hypotheses four and five were supported. As theorized, family functioning had a 
relationship with self-efficacy and quality of life. Although the results showed a negative 
relationship between family functioning as a predictor and the outcome variables self-efficacy and 
quality of life, the directional scoring of the family functioning scale is important to assess. 
Ridenour, Daley, and Reich (1999) explained that lower scores on this scale represent functional 
family operations, and higher scores indicated dysfunctional family operations. Thus according to 
the study findings, lower levels of family dysfunction increase scores on patient self-efficacy and 
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quality of life scales. These results are consistent with support in the literature that families can 
improve treatment outcomes for those in recovery (Edwards & Steinglass, 1995; Liddle, 2004; 
Lin, Wu, & Detels, 2011; Peters, Pontin, Lobban, & Morris, 2011).  
As previously noted, self-efficacy is when someone believes that they have the ability and 
resources to achieve a preferred result (Bandura, 1977; Bandura & Locke, 2003; Dolan, Martin, & 
Rohsenow, 2008). A well-functioning family according to Ridenour, Daley, and Reich (1999) is a 
system that can engage in problem solving, have good communication, well-established family 
roles, appropriate affective responsiveness and affective involvement, as well as behavioral 
control. It is plausible that someone would be more confident in their ability to reach a goal when 
they are supported by a system that engages well with problem solving, has healthy behavioral and 
affective responses, and good communication skills. Well-functioning family systems likely 
motivate the recovering addicts to achieve sobriety through forms of encouragement. Indeed, 
motivation has been found to be a predictor of self-efficacy in the substance abuse population 
(Dolan et al., 2007).  
Further, the substance abuse literature shows that many recovering addicts seek sobriety 
because of their family members (Booth et al., 1992; Room, Matzger, & Weisner, 2004). Thus if 
a patient has quality support, these family members may also be perceived as objects of motivation, 
and patients may want to make changes to maintain their strong connections with their family 
members.  Beyond the ability to motivate patients in substance abuse treatments, family systems 
also emulate each other’s coping mechanisms (Chassin & Ritter, 2001; Kilpatrick Acierno, 
Baunders, Resnick, Best, & Schnurr, 2000). It is possible that family members who are well 
functioning could also model examples of healthy coping mechanisms for recovering patients. 
Overall, results show that having healthy attachments where one feels connected and supported by 
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others, can lead to greater self-efficacy in substance abuse treatment. The findings from this study 
are consistent with previous research that highlights the impact of families in treatment (Ellis et 
al., 2004; Rhodes & Jason, 1990) and emphasizes that the functioning of the family is essential to 
one’s recovery more so than general tangible support.   
The finding that family functioning positively predicts quality of life for those in substance 
abuse recovery was also comprehensible. Referring to the current study’s “pathway from insecure 
attachment to methadone treatment” theory, early attachments can influence the quality of 
relationships. The quality of relationships influences the family system and the family’s overall 
functioning (Day, 2008; Nichols & Schwartz, 2004). A well-functioning family with healthy 
relationships could enhance a recovering addict’s quality of life in a variety of ways.  
Many changes take place when someone is rehabilitating from opiate addiction. This 
includes finding stable shelter and employment, improving their health, obtaining transportation 
to receive methadone treatment, taking care of their bodies and appearance, experiencing 
emotions, and managing social interactions and damaged relationships (Nettleton, Neale, & 
Pickering, 2011). Given the myriad of life adjustments that must be made while in recovery, 
receiving support from family members who can help problem solve with the patient would likely 
make a difference in how much they are able to benefit from treatment. Healthy family functioning 
is indicated by effective problem solving (Ridenour, Daley, & Reich, 1999). To expand on this, 
consider the family system characteristics of a person who may have a higher satisfaction with 
their health. Their satisfaction with their health may be attributed to having people in their lives 
who they could have communicated with about their health concerns, and then engage in problem 
solving with to reach more optimal outcomes. Additionally, it may be easier to communicate 
quality of life concerns with family members who display appropriate affective responsiveness 
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and involvement; which are also responses reflective of good family functioning (Ridenour, Daley, 
& Reich, 1999). Ultimately, this research indicates that healthy family functioning can influence 
a patient’s quality of life while in substance abuse treatment.  
Results show that being connected to a healthy family system with supportive relationships 
is of greater value than tangible support to patients, and that the presence of these healthy 
relationships are enough to improve one’s treatment response. Furthermore, because families are 
systems that influence one another (Day, 1995; Day, 2008; Nichols & Schwartz, 2004), once an 
addict is in recovery not only could this improve their quality of life, but this could improve the 
quality of life of their family members as well. According to the WHOQOL-B Group (1998), 
quality of life includes feelings of life enjoyment, feelings of purpose, and relationship satisfaction. 
If family members were involved and helpful in the addiction treatment, it is possible that this 
would improve the quality of life for the addict as well as the family members. This connects back 
to the concept of circular causality (Day, 2008). Essentially as the patient’s quality of life improves, 
so does their family system’s quality of life, which in turn further bolsters the patient’s quality of 
life. Research shows that family members could be either helpful or detrimental to a patient’s 
substance abuse recovery (Tracey et al., 2010). The findings from this study demonstrate that 
family functioning is a key variable in understanding how families can contribute to substance 
abuse treatment outcomes.   
It is important to also conceptualize the mechanisms underlying family functioning, and 
how this adversely influences feelings of self-efficacy and quality of life perceptions. Families 
have a homeostasis that requires the expectations and roles of each member to be fulfilled in order 
to maintain an internal balance within the family (Day, 2008). In the family dynamic literature, 
addiction can be conceptualized as a symptom of family dysfunction (Anderson, Goolishian, & 
  
 
74 
 
Windermand, 1986). For the member who is dependent on opioids, being an “addict” is their role 
in the family. For poorly functioning families, this subsequently sows the belief in the other family 
members that this person is the problem in the family. Family roles then emerge around this belief 
in order to manage the problem (Anderson, Goolishian, & Windermand, 1986). The formation of 
these roles due to the presence of addiction, consequentially diverts attention from underlying 
issues of the family’s dysfunction of which the addiction is a symptom (i.e. overinvolved mother, 
under involved father, trauma and abuse in the home, etc.) (Papero, 1995). 
As long as the “problem” family member is engaged in their addiction, everyone 
understands and maintains their roles, and the family sustains their homeostasis (Stelle & Scott, 
2007). Disequilibrium of the homeostasis can occur once the addict is in recovery (Stelle & Scott, 
2007). Families that are poorly functioning may not know how to adjust in response to the 
recovering addict’s new functioning level. Specifically, the addict’s previous enablers or former 
criticizers may not want to or know how to readjust. They may continue their avoidant, enabling, 
or ridiculing behavior as these are the scripts that they have been accustomed to following. As 
such, adjusting responses toward the patient while they are in recovery can be challenging for their 
family (Buchman & Reiner, 2009).  
As previously noted, many opiate addicted persons are the products of insecure attachment 
and possibly abusive relationships (Kang et al., 1999; Krausz, Saddichha, Strehlau, Taplin, Li, Al-
desouki, Schuetz, 2014; Stanton, 1978). In these systems, it is plausible that those in recovery may 
still be coping with self-pity or negative self-associations developed prior or during their addiction 
(Elgersma, Glashouwer, Penninx, Bockting, & Jong, 2013; White, 2001). Thus, self-efficacious 
beliefs may be very difficult to achieve. Aside from damaging self-perceptions, family systems 
with unhealthy attachments and poor relationships, may prove as discouraging or triggering for 
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patients (Brown, 1985; Ellis et al., 2004; O’Farrell et al., 1998; Tracey et al., 2010). These poorly 
functioning families could be triggering negative affect for recovering addicts, thus the patient’s 
belief in their abilities to abstain from drug use and to do well in treatment are understandably not 
very high. Additionally, those in recovery who feel that they are unsupported by family members 
and/or whose families may be adding stressors to the patient’s sobriety goals, may find it more 
challenging to reach satisfaction in other areas of their life. In consequence, if a patient’s family’s 
response is reflective of poor family functioning, this could impair self-efficacy and perceptions 
of quality of life while in recovery. 
Hypotheses seven, eight, and nine assessed if family functioning moderated the 
relationship between tangible support and the three treatment outcomes (self-efficacy, quality of 
life, and drug use). These three hypotheses were not substantiated by the data. When family 
functioning was entered into the moderating models assessing self-efficacy and quality of life as 
outcomes, family functioning showed to be significant. However, when the product variable was 
entered, these models were no longer significant. Being that the study’s data already demonstrated 
that tangible support did not have any significant bearing on one’s self-efficacy, quality of life, or 
drug use, there was no relationship for family functioning to moderate. As stated previously, 
dependency and addiction have biological and psychological influences (Dependency, 2012). Thus 
an external variable such as tangible support may not be substantial enough to influence these 
mechanisms. These analyses showed that when tangible support is given, no matter how well one’s 
family is functioning, that tangible support continues to have no effect on the treatment outcomes. 
Hypotheses three, six, and nine indicated that neither of the predictors (tangible support or 
family functioning) had a significant relationship with drug use as a treatment outcome. Although 
these hypotheses were not supported, this was an interesting finding because it illuminated that 
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family functioning and tangible support do not influence the addict’s drug use behaviors. Due to 
the fact that reducing drug use behavior is one of the target goals of many treatment programs, 
understanding what factors may or may not influence drug use is essential (Tiffany et al., 2012). 
Even though these findings are contradictory to previous literature that says social support is 
helpful for abstinence (Klingemann & Efionayi-Mäder, 1994), and that family problems predict 
opiate use (Scherbaum & Specka, 2008), a logical notion can still be deduced from the results of 
the current study.  
Opiate addiction is a disease that is chronic and cyclical. Drug relapses are common and 
considered a part of the recovery from opiate addiction (Scherbaum & Specka, 2008). Although 
society expects recovery to be a linear pattern, it is not (Witkiewitz, & Marlatt, 2007). Even if 
someone has been clean for many years, a relapse can still occur (Scherbaum & Specka, 2008). 
Also when looking specifically at an opioid treatment population, it is known that people in 
treatment are those who have been experiencing greater psychological difficulty and life distress 
(Rounsaville & Kleber, 1985) or have had challenges with stopping on their own (Scherbaum & 
Specka, 2008). Thus receiving support, as well as coming from a well-functioning family, could 
be helpful for someone who is wishing to end their illicit opiate addiction (with or without 
treatment). However, for those who utilize assistance from a treatment program, their needs may 
be more severe in which they had to enlist additional help.  
 It is also important to understand that not all patients are in treatment solely because they 
want to be clean and live a recovered lifestyle. For some, they’ve entered treatment for medical 
reasons or to meet the terms of their probation or to retain custody of their children (Scherbaum & 
Specka, 2008). Their motivation to be in treatment may not relate to a true desire to reduce drug 
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use, thus factors such as tangible support and family functioning would not have a relationship 
with whether or not they decided to use drugs.  
 Irrespective of one’s motivations, an individual’s behaviors are also essential for a 
successful recovery. Opiate use is just one of many behaviors that would need to be changed to 
have a successful recovery. Thus, if patients don’t change their behaviors and environment, they 
can easily slide back into the habit of drug use when all other maintained behaviors and 
environments are so familiar (Padgett, Henwood, Abrams, & Drake, 2008). Also, recovering 
addicts have reported that they feel they want to take the drug to feel “complete” (Nettleton, Neale, 
Pickering, 2011). Even though enrollment in a methadone program reduces heroin or pill 
dependency, the psychological addiction to the drug taking behavior may still be active. If a family 
member was providing social support for the primary reason that they would like to see a reduction 
in the patient’s drug use, it is plausible that there would not be a relationship between those two 
variables because drug use is just one of many behaviors exhibited in heroin addiction. It seems 
that it does not matter how well someone’s family is functioning, if other factors are in line for 
patients to permit themselves to use substances—there is a greater likelihood that they will use 
substances. Given these reasons, it is understandable that hypotheses three, six, and nine were not 
supported because tangible support and family functioning were not able to predict drug use 
behavior in this treatment population.   
Limitations and Future Directions 
There were a few limitations to the study, and several of these limitations highlight 
possibilities for future directions. One of the first limitations of this study, is that although family 
functioning was found to have a significant relationship with self-efficacy and quality of life as 
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treatment outcomes, family functioning has a smaller beta as a predictor. This shows that there are 
other variables that are accounting for these treatment outcomes. Although family functioning does 
impact self-efficacy and quality of life, it does not seem that these treatment outcomes are fully 
reliant on the patient’s family functioning.    
The quantitative measures used in the study had their benefits, however, qualitative 
measures could have provided more information; especially regarding a topic as complex as family 
relationships in an addicted population. A qualitative measure could encompass a holistic view of 
their relationships with their family. As according to patient feedback in debriefings, the Family 
Assessment Device-GS and the level of familial communication inquiry did not seem to be 
comprehensive enough to capture the sample’s relationships with their families. The patients felt 
limited in sharing their experiences via a few categories. Furthermore, through participant 
feedback most patients appeared as if they were answering questions about their peer or older adult 
family members. However, in some cases they could have been speaking about their children. It 
was important to not define who or what “family” was, to allow for the participants to share their 
experiences with who they considered family despite researcher bias of how a family system 
should be defined. However, this makes it challenging to know which relationships had the greatest 
influence or impairment for the participant, because they were not required to identify which 
relationships were addressed in their responses. Moreover, understanding which family members 
a participant was referring to in their question would have been helpful especially for those who 
reported that they have well-functioning families. Considering the “pathway from insecure 
attachment to methadone use,” belonging to a well-functioning family would be inconsistent with 
this theory. Without the definition of family it may be difficult for the researcher to obtain the 
picture of the entire family system. For example, patients’ insecure attachment could originate 
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from a missing father and an overinvolved mother who provided some support, or raised by 
grandparents because their parents were not active in their parental roles, or patients could have 
had caring parents who were often not home due to work (i.e. they provided tangible support but 
did not have as great of relationships). It is possible that some of these patient’s parents were not 
involved when they were growing up but are involved with them now in their adult lives. Any of 
these aforementioned scenarios could have fostered insecure attachment in a family system, while 
still leaving the possibility that a participant could currently report their family as well functioning. 
Ultimately, qualitative assessments and understanding which family members participants are 
referencing in their responses would be helpful in future assessments of family functioning in this 
population. 
The study’s findings opened the door for new inquiries regarding patients’ family 
functioning. In future studies, it may be beneficial to assess subsystem relationships between the 
patient and some of their respective family members. This would be opposed to solely assessing 
the functioning of the whole family system, as done in the current study. Using an assessment that 
specifically focuses on attachment in relationships such as the Relationship Style Questionnaire 
(Brennan, 1998), would also strengthen the study’s “pathway from insecure attachment to 
methadone use” theory. Another assessment that would be valuable would be a measure that 
specifically examines expectations from the family system and subsystems. The influence of 
family functioning on treatment outcomes could be different for someone whose family has high 
expectations of them but are low functioning compared to someone whose family has low 
expectations but are also low functioning. Comprehending the expectations of family members 
within the context of the family functioning could sharpen our understanding of how the family 
functioning influences treatment outcomes. This would give us more information about which 
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impaired relationships are having a greater influence on the patient’s self-efficacy and perceptions 
of quality of life.  
Even though this was a diverse population, there were enough similarities that would make 
some between group designs appealing for future research.  The results showed that socioeconomic 
status (SES), included as a covariate, and was a strong positive predictor of quality of life. 
Substance abuse treatment can improve quality of life (Maremmani, Pani, Pacini, Perugi, 2007; 
De Maeyer, Vanderplasschen, Lammertyn, van Nieuwenhuizen, Sabbe, Broekaert, 2011), hence 
why quality of life is commonly as a treatment outcome. So although managing substance 
dependency is an important part of recovery, ensuring that resources are available to combat SES 
challenges are also important, and should be a co-occurring resource with treatment (McLellan, 
Hagan, Levine, Gould, Meyers, Bencivengo, & Durell, 1998). A study that compares treatment 
outcomes for patients enrolled in a treatment program for a higher SES population with greater 
resources (i.e. private pay) to patients enrolled in a treatment program for a lower SES population 
with less resources (i.e. Medicaid) would be of value. It is known that people do not want to 
identify as “lower class,” even when according to government data this would be the economic 
class that they would be categorized in (Class Matters, 2013). Having participants clearly identify 
their household income range, would make studies looking into SES more accurate.  
It would also be useful to run a comparison between genders. The analysis demonstrated 
that gender, included as a covariate, was a predictor of patient self-efficacy. The literature 
demonstrates that social support can influence the recovery process differently for women and men 
(Davis & Jason, 2005). It is plausible that the varied impact of social support by gender could 
reflect in varied perceptions of self-efficacy. Thus, this should also be further explored in future 
studies. Additional groups that would be beneficial to comparatively examine would be those 
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whose participants who are younger in age or groups with a broader range of racial diversity. Also, 
being that the sample was a treatment population, this could be limiting in understanding 
recovering addicts as a whole. Greater insight could be provided if a population receiving treatment 
resources was compared to a population who were active users but not in a medically assisted 
treatment (MAT) program yet. This comparison would illuminate if matriculation in treatment 
makes patients more susceptible to the influence of family functioning, or if the two populations 
are similar when it comes to these predictors.  
Another variable, included as a covariate, that showed to be influential in the analyses was 
non-opioid drug use as a predictor of opioid drug use. Being that non-opioid use was a categorical 
variable, the study findings showed that the category “no non-opioid drug usage” was specifically 
a great predictor of whether or not one used opioids in the past month. This demonstrates that 
treatment programs can focus on how any drug use can be indicative of the likelihood to use 
opiates. If a patient allows themselves to use some drugs, it is not unlikely that they will engage in 
using their drug of choice at some point in their recovery as well. Seven percent of the patients in 
this population did not use opiate drugs in the past month, but were found to still be using non-
opiate drugs (i.e. cocaine, marijuana, benzodiazepines, etc.). This shows that some patients may 
still be in the pattern of making excuses for their behavior, and possibly not being honest with 
themselves about where they are in their recovery. Essentially, a person’s actual mindset is what 
appears to be important. Recovering addicts’ beliefs about drug use overall is very critical, more 
so than the use of the preferred drug itself. How committed a patient is to not use any drugs is an 
indicator of adherence to treatment.  
Even though this study looked primarily at opiate drug use through the self-medication 
hypothesis, it would be important for future studies to consider how poly-drug use factors into this 
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theory. Many heroin users are poly drug users as well, however, the methadone treatment only 
treats their opiate addiction (Darke & Ross 1997). It is vital to know what emotional needs are 
assuaged by poly drug use, which then continue to drive the use of these non-opioid drugs even 
after they began opiate substance abuse treatment. Understanding contributing factors to poly drug 
use, may help researchers understand what mechanisms are still static in the lives of recovering 
addicts. It is critical to comprehend the mechanisms that maintain non-opioid drug usage, being 
that the ability to abstain from non-opiate drugs is also a predictor of abstention from opiates. 
Hence, replications of this study should expand the self-medication theory to poly drug usage as 
well.  
A final statement about a current limitation that should be accounted for in future studies 
is allowing participants to report their reasoning for entering treatment. For example, those who 
are entering treatment in order to have better relationships with their families, would likely be 
more influenced by their family functioning than someone who entered treatment as a condition 
of their probation. Discerning these factors would shed light on patient motivations, and in turn 
what factors would be more predicative of their treatment outcomes.  
Strengths and Implications 
One of the strengths of this study is that it adds to the growing methadone literature. Given 
the rising drug use population and the burdening costs associated with drug use, our nation’s 
interest in efficacious substance treatment remains strong (Nationwide Trends, 2015; Tiffany, 
2012). The findings of this study stem from an area in substance abuse that has not been 
specifically assessed in the literature, which is understanding how tangible support and family 
functioning specifically influence treatment outcomes. It is now known that tangible support does 
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not influence treatment outcomes, and that family functioning is an important underlying construct 
to achieve self-efficacy and quality of life while in treatments. Due to the uniqueness of these 
concepts, these findings have not been seen in the substance abuse literature and could add a great 
deal to how the field can conceptualize family support and influence. These results highlight 
overlooked mechanisms during the recovery from substance use that need more attention. 
Additional strengths of this study include that it featured a heavily ethnic minority 
participant sample. Similar to the growing national interest in drug using populations, there is also 
interest in the field of strengthening our understanding of underserved and under examined 
populations; especially ethnic minorities (Betancourt & Lopez, 1993; Henrich, Heine, & 
Norenzayan, 2010; Medin, & Lee, 2012). Furthermore, this study featured a good sized sample 
that was above the minimum sample size requirement to reach the desired effect size originally set 
out in the research proposal.  
Other implications of this research are that it provided a clear development of a theory that 
demonstrates the pathway from insecure attachment to methadone treatment. This pathway 
incorporated attachment literature, personal development and family dynamic themes, the 
biological mechanisms underlying attachment to addiction, and how methadone treatment is an 
attempt to resolve the issues consequential of the processes that develop over time. The lucidity of 
this theory would be helpful in training the many professionals and paraprofessionals who work 
directly with these populations in understanding the foundations of their addiction, and 
understanding the chronic psychological pain that is present with these patients that must be 
addressed through treatment. 
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Clinicians can use findings from this study to inform the treatment of addicted patients and 
their families. For family therapy practices who see families where addiction is in the system, or 
for substance abuse treatment facilities who work with the families of their patients, it would be 
essential to understand that patient’s self-efficacy and the perception of their quality of life are 
influenced by their family members. Therapists could use this knowledge to inform their 
interventions such as dispelling the patient’s negative self-perceptions, strengthening their 
cognitive association skills, and working with families towards role readjustment in order to be 
more supportive of the patient. Future studies could look at the efficacy of such interventions 
inspired by the current research, and perhaps develop treatment modules or programs around these 
findings. Also, counselors may be working with families who believe that they can provide 
tangible support and that this support is solely going to make a considerable difference for the 
recovery of their loved one. Therapists can inform these families that this is an unsubstantiated 
assumption, and direct them to more effective interventions or ways to support the patient. Given 
the findings of this study, when working with addicted patients clinicians should make sure to 
inquire about patients’ family functioning. Treatment programs know that quality of life must be 
improved with treatment (Picci et al., 2014). So if family dysfunction is adversely influencing a 
patient’s perceptions of their quality of life, it would be important for the facility to address through 
individual or group therapy, or support through additional resources. 
Finally, this study provides a great foundation for future directions with an opiate using 
population. In regards to how family influences treatment, future researchers can use qualitative 
measures, they can look at family expectations, caregiver attachment, as well as clearly identified 
sub-system relationships. Comparisons with different populations, such as SES, race, age, and 
treatment matriculation could provide specific information about which groups are most affected 
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by family functioning through the various treatment outcomes. Incorporating poly drug usage in 
the self-medicating hypothesis of an opiate addicted population, would help with the understanding 
of the factors that influence relapse. Also, understanding the implications of when someone in 
recovery is able to take a step back from any and all drug usage, and what that means for their 
opiate use recovery. 
Conclusion 
This study aimed to examine an understudied area of the substance abuse literature, which 
was the influence of tangible support and family functioning on treatment outcomes. The results 
showed that tangible support has no influence on treatment outcomes, and that neither tangible 
support nor family functioning were able to predict drug use behavior while in treatment. Family 
functioning was found to be a positive predictor of patient self-efficacy and quality of life. Even 
though some of the hypotheses were not supported, the hypotheses that were supported still 
reinforced the “pathway from insecure attachment to methadone use” theory. The findings were 
able to illustrate that how these foundational relationships could influence drug use, but that family 
functioning can also shape one’s recovery from drug use. The current research brought new 
findings to the literature and opened the door for exciting future directions to be explored.  
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Appendix A 
 
DTCQ-8  
Shortened Version of The Drug-Taking Confidence Questionnaire 
Listed below are a number of situations or events in which some people experience an opioid abuse problem.  
  
Imagine yourself as you are right now in each of these situations.  Indicate on the scale provided how confident you are that 
you will be able to resist the urge to use opioids heavily in that situation.  
  
Circle 100 if you are 100% confident right now that you could resist the urge to use opioids heavily, 80 if you are 80% confident; 
60 if you are 60% confident.  If you are more unconfident than confident, circle 40 to indicate that you are only 40% confident 
that you could resist the urge to use heavily; 20 for 20% confident; 0 if you have no confidence at all about that situation.  
 
I would be able to resist the urge to use my opioid of choice heavily:  
  
                      Not at all          Very  
                      Confident          
      
Confident  
1. If I were angry at the way things had turned out.    0    20   40    60   80   100  
  
2. If I had trouble sleeping.  
  
0  
  
20  
  
40  
   
60  
  
80  
  
100  
  
3. If I remembered something good that had happened.  
  
0  
  
20  
  
40  
   
60  
  
80  
  
100  
  
4. If I wanted to find out whether I could use opioids occasionally 
without getting hooked.  
  
  
0  
  
20  
  
40  
   
60  
  
80  
  
100  
5. If I unexpectedly found some opioids or happened to see 
something that reminded me of using opioids.  
  
0  
  
20  
  
40  
 
  
60  
  
80  
  
100  
  
6. If other people treated me unfairly or interfered with my plans.  
  
0  
  
20  
  
40  
   
60  
  
80  
  
100  
  
7. If I were out with friends and they kept suggesting we go 
somewhere and use opioids.  
  
0  
  
20  
  
40  
   
60  
  
80  
  
100  
  
8. If I wanted to celebrate with a friend.  
  
0  
  
20  
  
40  
   
60  
  
80  
  
100  
 
  
  
Office Use Only:  Global Self-Efficacy Score: _________ or ________%  
  
_______  
  1997, Centre for Addiction and Mental Health, Used by permission.  
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Appendix B 
 
Inventory of Socially Supportive Behaviors (ISSB)  
  
INSTRUCTIONS   
  
We are interested in learning about some of the ways that you feel your family has 
helped you or tried to make life more pleasant for you over the past four weeks.  Below 
you will find a list of activities that family members might have done for you, to you, or 
with you in recent weeks.  Please read each item carefully and indicate how often these 
activities happened to you during the past four weeks.  
Please read each item carefully and select the rating that you think is the most accurate   
During the past four weeks, how often did your family do these activities for you, to 
you, or with you:  
 
 
 
   
 
 
Provided you with a place to stay      
Pitched in to help you do something that you needed 
to be done 
     
Gave you over $25      
Loaned or gave you something that you needed      
Gave you transportation      
Gave you under $25      
Went with you to someone who could take action      
Provided you with a place where you could get away 
for awhile 
     
Loaned you over $25      
Watched after your possessions when you were away      
Looked after a family member when you were away      
  
N
o
t 
at
 a
ll
 
O
n
ce
 o
r 
tw
ic
e
 
 
N
o
t 
at
 a
ll 
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Appendix C 
Family Assessment Device - General Functioning Scale 
We are interested in what you perceive are your family’s strengths and needs. After reading  
each statement below, decide if you strongly agree (SA), agree (A), disagree (D), or strongly disagree (SD) with the  
statement as it reflects how you feel about your family. 
 
1. Planning family activities is difficult because we misunderstand each other. 
__SA __A __D 
2. In times of crisis we can turn to each other for support. 
__SD  
__SA __A __D 
3. We cannot talk to each other about the sadness we feel. 
__SD  
__SA __A 
4. Individuals are accepted for what they are. 
__D __SD  
__SA __A 
5. We avoid discussing our fears and concerns. 
__D __SD  
__SA __A 
6. We can express feelings to each other. 
__D __SD  
__SA __A 
7. There are lots of bad feelings in the family. 
__D __SD  
__SA __A 
8. We feel accepted for what we are. 
__D __SD  
__SA __A 
9. Making decisions is a problem for our family. 
__D __SD  
__SA __A __D __SD  
10. We are able to make decisions about how to solve problems. 
__SA __A __D 
11. We don't get along well together. 
__SD  
__SA __A __D 
12. We confide in each other. 
__SD  
__SA __A __D __SD 
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Appendix  
Appendix D 
 
World Health Organization Quality of Life—BREF 
WHOQOL–BREF 
 
 Very 
Low 
Low Moderate High Very 
High 
1.    How would you rate your 
quality of life?  
1 
(very low) 
2 3 
(moderate) 
4 5 
(very high) 
2.    How satisfied are you with your 
health? 
1 
(very 
unsatisfied) 
2 3 
(moderately 
satisfied) 
4 5 
(very 
satisfied) 
3. To what extent do you feel that 
(physical) pain prevents you 
from doing what you need to do? 
1 
(very little) 
2 3 
(moderately) 
4 5 
(very much) 
4. How much do you need any 
medical treatment to function in 
your daily life? 
1 
(very little) 
2 3 
(moderately) 
4 5 
(very much) 
5. How much do you enjoy life? 1 
(very little) 
2 3 
(moderately) 
4 5 
(very much) 
6. To what extent do you feel your 
life to be meaningful? 
1 
(very little 
meaning) 
2 3 
(moderate 
meaning) 
4 5 
(very much 
meaning) 
7. How well are you able to 
concentrate? 
1 
(very 
poorly) 
2 3 
(moderately) 
4 5 
(very well) 
8. How safe do you feel in your 
daily life? 
1 
(very 
unsafe) 
2 3 
(moderately 
safe) 
4 5 
(very safe) 
9. How healthy is your physical 
environment? 
1 
(very 
unhealthy) 
2 3 
(moderately 
healthy) 
4 5 
(very 
healthy) 
10. Do you have enough energy for 
everyday life? 
1 
(very little) 
2 3 
(moderate) 
4 5 
(very much) 
11. Are you able to accept your 
bodily appearance? 
1 
(very 
unable) 
2 3 
(moderately) 
4 5 
(very able) 
12. Have you enough money to meet 
your needs? 
1 
(very little) 
2 3 
(moderately) 
4 5 
(very much) 
13. How available to you is the 
information that you need in 
your day-to-day life? 
1 
(very 
unavailable) 
2 3 
(moderately) 
4 5 
(very 
available) 
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14. To what extent do you have the 
opportunity for leisure activities? 
1 
(very little) 
2 3 
(moderately) 
4 5 
(very much) 
15. How well are you able to get 
around? 
1 
(very little) 
2 3 
(moderately) 
4 5 
(very much) 
16. How satisfied are you with your 
sleep? 
1 
(very 
unsatisfied) 
2 3 
(moderately 
satisfied) 
4 5 
(very 
satisfied) 
17. How satisfied are you with your 
ability to perform your daily 
living activities? 
1 
(very 
unsatisfied) 
2 3 
(moderately 
satisfied) 
4 5 
(very 
satisfied) 
18. How satisfied are you with your 
capacity for work? 
1 
(very 
unsatisfied) 
2 3 
(moderately 
satisfied) 
4 5 
(very 
satisfied) 
19. How satisfied are you with 
yourself? 
1 
(very 
unsatisfied) 
2 3 
(moderately 
satisfied) 
4 5 
(very 
satisfied) 
20. How satisfied are you with your 
personal relationships? 
1 
(very 
unsatisfied) 
2 3 
(moderately 
satisfied) 
4 5 
(very 
satisfied) 
21. How satisfied are you with your 
sex life? 
1 
(very 
unsatisfied) 
2 3 
(moderately 
satisfied) 
4 5 
(very 
satisfied) 
22. How satisfied are you with the 
support you get from your 
friends? 
1 
(very 
unsatisfied) 
2 3 
(moderately 
satisfied) 
4 5 
(very 
satisfied) 
23. How satisfied are you with the 
conditions of your living place? 
1 
(very 
unsatisfied) 
2 3 
(moderately 
satisfied) 
4 5 
(very 
satisfied) 
24. How satisfied are you with your 
access to health services? 
1 
(very 
unsatisfied) 
2 3 
(moderately 
satisfied) 
4 5 
(very 
satisfied) 
25. How satisfied are you with your 
transport? 
1 
(very 
unsatisfied) 
2 3 
(moderately 
satisfied) 
4 5 
(very 
satisfied) 
26. How often do you have negative 
feelings such as blue mood, 
despair, anxiety, depression 
1 
(very 
infrequent) 
2 3 
(moderately) 
4 5 
(very 
frequently) 
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Appendix E 
 
Demographic Questions  
1. Age:  __________        2. Sex:         Male            Female       Other 
3. Highest Education:   Some high school   High School Degree or GED   Freshman        
  Sophomore  Junior   Senior  Bachelors Degree   Graduate or Professional Degree 
4. Socioeconomic Status:   Lower      Middle         Upper   
5. Race:  Black   White   Other ____________________________ 
6. Relationship Status:   Single    Dating   Engaged    Married   Separated                     
  Divorced    Other __________________________________  
7. Parental Status:   No children    Biological (Primary Caretaker)   Biological (Not Primary 
Caretaker)   Step (Primary Caretaker)  Other _______________________________  
8. Opioid(s) of Choice ___________________________________________________________ 
9. Age of initial use _______ 10. Month & Year that you started Treatment _________________ 
11. Number of enrollments in substance abuse treatment ________________ 
12. Did your mother abuse substances during your childhood?                    
        Yes         No        No relationship with a mother figure  
        If so, which substances? _________________________________ 
13. Did your father abuse substances during your childhood?         
       Yes         No        No relationship with a father figure   
       If so, which substances? _________________________________ 
14. Did another member of your family abuse substances during your childhood?         
       Yes         No        No relationship with other family members  
       If so, which substances? _________________________________  
15. What is your current level of family communication? 
 Daily  A few times a week   A few times a month  A few times a year   Once a year or less   
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